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Radial adult neural stem cells (rNSCs) in the hippocampus remain quiescent until 
activated to both divide and differentiate into functional neurons that can then integrate into the 
existing local circuit and participate in parallel yet complementary information processing with 
existing neurons in the hippocampus.  Continuous neurogenesis requires coordination between 
the local niche cell types that regulate rNSCs.  However, virtually nothing is known about how 
local niche cells are coordinated at the circuit level to regulate rNSCs and neurogenesis.  Here 
we identify cholecystokinin (CCK) as a master regulator of neurogenic niche cells in the 
hippocampus.  Stimulating CCK release from local CCK expressing interneurons results in 
activation of rNSCs and a concomitant increase in neurogenesis.  In parallel, CCK also exerts an 
overall inhibitory tone to the dentate gyrus (DG) through inhibition of excitatory neurons, thus 
preventing depletion of the rNSC pool.  The effects of CCK on neurogenesis are mediated by 
glutamatergic signaling from astrocytes on to rNSCs, thus driving rNSC activation.  
Furthermore, inhibition of CCK synthesis impairs rNSC proliferation and also drives astrocyte 
reactivity, mirroring the phenotypic effects of Alzheimer’s disease in mice.  Taken together, 
these findings identify a novel role for CCK in coordination of the local niche cell types that 
sustain neurogenesis and demonstrate that the loss of CCK results in symptoms associated with 
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CHAPTER 1 INTRODUCTION 
 
Early evidence for neurogenesis 
The earliest evidence of mammalian adult neurogenesis occurred when [3-H]-
thymidine incorporation was first observed in hippocampal neurons of adult rats1.  As neurons 
lack the capacity to proliferate, thymidine incorporation would only be possible if those 
neurons were derived from a stem cell or progenitor population undergoing cell division at the 
time of [3-H]-thymidine injection.  However, it wasn’t until decades later, with technological 
improvements in immunolabeling and imaging, that the theory of adult neurogenesis occurring 
in mammals became more widely accepted by the neuroscience field2.  The theory of adult 
neurogenesis has now gone from being largely dismissed by neuroscientists to being accepted 
as an important part of healthy brain function and a potential target for therapeutics that could 
improve cognitive abilities or be used in the treatment of neurodegenerative diseases.   
 
Evidence for the presence of hippocampal neurogenesis in humans 
One early paper using post mortem tissue from patients treated with the thymidine 
analog, bromodeoxyuridine (BrdU) sought to determine whether adult neurogenesis occurs in 
humans or was restricted to song birds and rodents.  Using postmortem brain tissue from 
patients that had been treated with BrdU along with immunofluorescent labeling of neuronal 
markers, this group observed the presence of nuclear BrdU in the granule cell layer of the adult 
dentate gyrus. Furthermore, Brdu+ nuclei were found to co-localize with one of several 
neuronal markers including NeuN, calbindin, and NSE3.  A more recent paper used the elevated 
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labels of 14C in the atmosphere during the nuclear bomb tests of the 1950s and 1960s to 
retrospectively “birth date” neurons in the hippocampus. Using this technique, the group was 
able to study the dynamics of human hippocampal neurogenesis and estimated a ~1.75% 
annual turnover rate of neurons within the renewable fraction of neurons in the hippocampus4.  
Despite these, and other papers demonstrating that adult neurogenesis does in fact take place 
in humans, one recent high profile paper claimed that the number of progenitors and immature 
neurons in the adult human hippocampus declines sharply with age to undetectable levels in 
adulthood.  However, the findings of this paper were quickly refuted as several groups argued 
that 1) the diseased tissue used was not representative of neurogenesis that takes place in 
healthy adult humans 2) the delay between patient death and tissue fixation was far too long 
for proper preservation of neuronal markers (doublecortinin in particular) which are 
notoriously sensitive to post mortem degradation 3) proper stereological principles were not 
applied to the quantitative estimates used to determine the number of adult born neurons 
present in the tissue5.  Furthermore, new evidence for human adult neurogenesis quickly 
emerged from groups using improved techniques for tissue preservation, tissue from healthy 
patients, and immunohistochemistry techniques that had been thoroughly optimized for use in 
human tissues6,7.  While a minority of detractors of adult neurogenesis still argue against its 
existence in humans despite the mounting evidence that says otherwise, the field of 
neuroscience as whole still very much believes that adult neurogenesis does occur in humans 
and continues to study it in both animal models and through less invasive methods in humans.  
Furthermore, the medical community has also embraced the therapeutic potential of studying 
neurogenesis as evidenced by ongoing clinical trials that aim to further understand the role of 
adult neurogenesis in human cognition and how it is affected by disease (clinicaltrials.gov, 
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NCT03457870, NCT01329926, NCT02906384).  As novel techniques for studying adult 
neurogenesis in human emerge, we will gain a better understanding of the process of human 
adult neurogenesis and the role it plays in human cognitive functions. Furthermore, we will be 
able to harness adult neurogenesis in the treatment of human diseases and also design effective 
treatments for diseases resulting from defects in adult neurogenesis. 
 
Overview of adult neurogenesis 
In both humans and mice, the stem cell population from which adult born neurons are 
derived resides in the dentate gyrus (DG) region of the hippocampus and are known as radial-
glia like neural stems cells (rNSCs).  The process of neurogenesis occurs in a series of discrete 
stages which can be identified in vivo through expression of specific protein makers (Figure 
1-1).  While the vast majority of rNSCs are quiescent at any given time (~95%), a number of 
external stimuli are capable of inducing rNSCs to enter the cell cycle and undergo cell 
division8.  Following cell division, newly divided rNSCs undergo the process of neuronal 
differentiation to produce fully functional neurons that can then integrate into the existing local 
circuit and contribute to specific brain functions, including learning and memory, stress 
response, and mood regulation.  Furthermore, rNSCs can also maintain their rNSC identity 
after cell division to prevent depletion of the rNSC pool9.  
 
The role of adult neurogenesis in behavior 
The hippocampus region of the brain is widely associated with a number of different 
behaviors associated with learning and memory, emotions, and stress response 10–12.  
Interestingly, adult neurogenesis is also closely associated with the same hippocampal 
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dependent behaviors.  Several early papers used crude ablation techniques to inhibit 
neurogenesis to determine the role of adult neurogenesis in learning and memory associated 
tasks, as well as the role of adult neurogenesis in mediating the effects of antidepressants.  
Targeted X ray radiation to the hippocampus prevents proliferation of rNSCs and neural 
progenitors and thus effectively blocks adult neurogenesis13.  Early evidence from these crude 
studies suggested that ablation of adult neurogenesis impaired spatial learning and memory14.  
However, this remained highly controversial as x-ray radiation lacked specificity and likely 
resulted in side effects that could confound results15.  The requirement of adult neurogenesis 
in spatial learning and memory was later re-confirmed in experiments using newer, cleaner 
techniques for inhibition of neurogenesis10. The development of transgenic mice that express 
pro-apoptotic genes in neural progenitors and rNSCs provided a novel way to selectively ablate 
neurogenesis with fewer detrimental effects than radiation16.    Using this technique, it was 
discovered that mice with genetic ablation of adult neurogenesis are more negatively impacted 
by stress and exhibit increased depressive like behaviors in response to stress.  Furthermore, 
their response to stress was found to be mediated by adult born neurons17.  Taken together, 
these papers highlight the importance of adult neurogenesis to a number of different 
hippocampal associated behaviors and thus is it is easy to see why further understanding the 
role adult neurogenesis plays in behavior might prove beneficial in the treatment of diseases 
associated with cognitive defects that are linked to these behaviors.  
 
Harnessing adult neural stem cells in the treatment of neurological disease. 
rNSCs reside in a specialized niche within the DG that consists of highly diverse cell 
types, including excitatory granule cells (GCs) and mossy cells (MCs), distinct types of 
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inhibitory interneurons, and glial cells.  External stimuli can activate local cell types of the DG, 
which then regulate rNSC activation and differentiation either cell automonously through 
release of factors directly to rNSCs or non-cell automonously through activation or inhibition 
of other local cell types4,9.  This process by which external stimuli can regulate rNSC activity 
is termed “activity dependent adult neurogenesis”. Understanding the mechanisms by which 
DG interneurons regulate rNSCs will be key to developing new therapies in which 
pharmacological or genetic manipulation of rNSCs restores the cognitive functions that are 
disrupted in the many pathological conditions associated with defective adult neurogenesis. 
 
The impact of external stimuli on adult neurogenesis 
While cells at any stage of neurogenesis do have some capacity to respond to external 
stimuli, one paper that used single cell sequencing of quiescent rNSCs, activated rNSCs, and 
neuronally committed progenitors discovered the rNSCs express a wide variety of cell surface 
receptors that are then downregulated as the cell enters the progenitor stage18.  This would 
suggest that while neuronal differentiation is largely the result of intrinsic, pre-programmed 
transcriptional mechanisms, rNSC activity is highly influenced by external signaling.  A 
number of papers have also demonstrated that external stimuli do in fact regulate rNSC activity 
and neurogenesis.  One such paper used co-cultures of endothelial cells and adult neural stem 
cells to demonstrate that factors released from endothelial cells promote increased proliferation 
and production of new neurons from adult neural stem cells19.  Co-culturing of adult neural 
stem cells with endothelial cells resulted in greater self-renewal and production of progenitor 
cells than those cultured with neurons.  Furthermore, self-renewal and progenitor production 
was blocked with the introduction of a Notch inhibitor to the culture, which also prevented 
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expression of Hes1 in neural stem cells.  This would indicate that endothelial cells activate 
neural stem cell proliferation through activation of the Notch signaling pathway on neural stem 
cells. This finding that endothelial cells drive NSC proliferation and differentiation in culture 
has even more relevance when compared with a previous paper that looked at the relationship 
between stem cells in the subgranular zone (SGZ) and the local vasculature of this region.  This 
paper demonstrated that neural stem cells in the SGZ form dense clusters around the 
microvasculture of the SGZ and thus are in close proximity to endothelial cells which would 
further suggest a role for endothelial cells in regulation of rNSCs20.  Two other papers also 
highlight the role of another external signaling molecule, bone morphogenic protein (BMP), 
in the maintenance of rNSC quiescence.  The earlier paper first demonstrated that the addition 
of Noggin, an inhibitor of BMP signaling, to SGZ derived adult neural stem cell cultures 
resulted in increased proliferation21.  This would suggest that BMP potentially plays a role in 
maintaining adult neural stem cell quiescence.  Therefore, the later paper then investigated the 
effect of BMP signaling on rNSC activity22.  Genetic ablation of bone morphogenetic protein 
receptor, type IA (Bmpr1a) or knockout of Smad4 (a downstream effector of BMP signaling) 
both resulted in increased proliferation of rNSCs, thus demonstrating the role of BMP in 
maintaining rNSC quiescence.  Taken together, these papers highlight the heavy influence that 
external signaling factors can have on rNSCs and neurogenesis.  The source of BMP in the DG 
is believed to be mostly from microglia23, however, as the DG is also heavily populated with 
neurons, neurotransmitters from either neuronal or astrocytic sources also play a role in 
external regulation of rNSC activity.  Gamma aminobutyric acid (GABA), the primary 
inhibitory neurotransmitter in the brain, released from local Parvalbumin+ (PV) interneurons 
in the DG induces rNSC quiescence and survival of newborn neuronal progeny through 
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activation of GABAAR on neural stem cells24,25.  Furthermore, glutamate, the primary 
excitatory neurotransmitter in the brain, has also been shown to promote rNSC proliferation 
through activation of metabotropic glutamate receptors on neural stem cells26,27.  Taken 
together, there appears to be mounting evidence for the ability of external stimuli to activate 
neural stem cells and so identifying new mechanisms by which external stimuli might regulate 
rNSC activity and neurogenesis will be key to understanding how neurogenesis is regulated. 
 
DG interneurons regulates rNSC activity and neurogenesis 
DG interneurons have dendritic and axonal projections terminating at DG boundaries 
but also have highly diverse afferent and efferent connections with other regions of the brain. 
These cells are also highly heterogeneous, with distinct morphological, genetic, and 
electrophysiological properties. Therefore, different classes of interneurons are likely to exert 
very different effects on local niche cells and rNSCs28,29.  While dentate PV interneurons 
release GABA as their main neurotransmitter, many local interneurons co-release GABA and 
neuropeptides. Neuropeptides are neuromodulators that can diffuse a long distance and bind 
G-protein coupled receptors expressed in multiple niche cell types with high affinity. 
Therefore, neuropeptides could potentially exert extremely broad and potent effects on 
multiple cell types within the DG when they are present. This raises an important question as 
to whether endogenous neuropeptides, when co-released from local interneurons, can serve as 
a master coordinator of the activities of local niche cells and thus regulate rNSCs and 
hippocampal neurogenesis.  Determining how individual interneuronal subtypes regulate 




Cholecystokinin interneurons as potential modulators of neurogenesis 
In this study, we focus on the role of cholecystokinin (CCK), released from local CCK 
interneurons, in regulating rNSCs and neurogenesis. CCK is the most abundant neuropeptide 
in the adult brain and is  expressed at very high levels in the hippocampus30.  Furthermore, the 
receptors for CCK, CCK2 receptors (CCK2Rs), are also extremely abundant in adult DG31,32 
which would suggest that this peptide could have an important functional significance in the 
neurogenic niche and potentially regulate rNSC activity.  As CCK and CCK receptors have 
been previously demonstrated to drive proliferation and regulate differentiation in a number of 
different cell types, one possibility is that CCK could directly influence rNSC activity through 
activation of CCK2Rs on rNSCs33,34.  However, single cell sequencing of rNSCs did not detect 
expression of CCK2R in any of the cells that were sequenced and thus it is unlikely that rNSCs 
actually express CCK2R18.  This would then rule out the possibility that CCK directly activates 
rNSCs and instead suggests that, if CCK does in fact regulate adult neurogenesis, it is through 
an intermediate cell type.  CCK from CCK interneurons could activate one or more of the 
intermediate cell types in the neurogenic niche which would then influence rNSC activity 
through release of factors to rNSCs.  This could be through activation of cell types that have 
been previously demonstrated to regulate adult neurogenesis such as granule cells, mossy cells, 
or PV interneurons25,35, or through activation of another cell type in the DG that has not yet 
been shown to regulate neurogenesis.  To date, the knowledge on how local niche cells are 
coordinated at the circuit level to regulate rNSCs and hippocampal neurogenesis is largely 
absent. Could CCK regulate rNSC activity and support sustainable hippocampal neurogenesis 




Technical challenges in studying the role of CCK in regulation of adult neurogenesis 
A combination of technical and conceptual challenges have made it previously 
impossible to effectively study the role of CCK on rNSC activity including 1) the lack of tools 
for selective targeting of dentate CCK cells 2) the multiple releasing components from CCK 
interneurons (GABA, CCK, and glutamate), which significantly increases the difficulty of 
isolating the effect of endogenous CCK alone, and 3) the broad actions of CCK on the 
neurogenic niche by interacting with multiple cell types expressing CCK2Rs which could then 
exert indirect effects on rNSC behavior36–39.  Two previous papers attempted to identify the 
role of CCK in regulation of rNSC and neurogenesis.  One group compared cell proliferation 
in a different neurogenic niche known as the subventricular zone (SVZ) between wild type and 
CCK1 receptor (CCK1R) knockout mice.  However, the SVZ is an entirely different 
neurogenic region than the SGZ and thus it is difficult to extrapolate the relevancy of these 
results to SGZ neurogenesis.  Furthermore, CCK1R is largely absent from the brain and so the 
observed defect was likely due to a defect in a different tissue that then indirectly influenced 
adult neurogenesis40,41.  The second paper quantified proliferation in the rat hippocampus after 
systematic administration of CCK peptide via tail vein injection42.  However, the results of this 
paper are also difficult to interpret as CCK peptide does not cross the blood brain barrier and 
so tail vein injection of the peptide would never actually reach the hippocampus43.  Therefore, 
a much more thorough investigation of the possible role CCK in regulating adult neurogenesis 
is needed.  This type of study will require 1) selective activation of CCK interneurons in the 
DG 2) cell type specific quantifications of rNSC proliferation and neurogenesis 3) a thorough 
look at all DG cell types to determine if any are required for CCK dependent regulation of 
rNSCs and neurogenesis. 
10 
 
Here we address the previous challenges to this study and report that dentate CCK 
interneurons serve as a critical niche component that utilize endogenous CCK to regulate the 
key behaviors of rNSCs via local astrocytes, while maintaining an inhibitory tone to prevent 
hippocampal hyperexcitability and support sustainable neurogenesis. Using a series of circuit-
based manipulations, we demonstrated that stimulating CCK release depolarizes rNSCs and 
promotes rNSC proliferation through an astrocyte-mediated glutamatergic signaling cascade. 
Interestingly, stimulating CCK release also exerts an inhibitory tone to the DG by inhibiting 
excitatory neurons through activation of local interneurons, which leads to increased 
neurogenesis without rNSC pool depletion. In contrast, suppressing CCK release induces 
reactive astrocytes, neuroinflammation, and impaired proliferation of rNSCs and newborn 
progeny. Furthermore, we found reduced CCK in the DG of an Alzheimer’s disease (AD) 
mouse model, which correlates with increased astrogliosis and decreased proliferation of 
rNSCs and newborn progeny. Our findings provide novel circuit-based information on how 
the neuromodulator CCK regulates rNSCs and hippocampal neurogenesis through 




Figure 1-1: Different stages of adult neurogenesis are identified by expression of specific 
protein markers.   
Expression of specific protein markers distinguishes between rNSCs, progenitors, 
neuroblasts, immature neurons, and mature neurons in the DG. (SGZ: Subgranular Zone.  










CHAPTER 2 RESULTS 
 
Activation of local CCK interneurons induces a robust depolarization in rNSCs 
through CCK2R-mediated signaling 
Previous studies used cre-dependent recombinant viruses in combination with CCK-
cre driver mouse lines for selective expression of transgenes in CCK interneurons in the DG. 
However, lack of specificity in the existing CCK-Cre mouse lines resulted in off- target 
labeling of non CCK+ types44.  Other groups attempted to address this specificity issue by 
using intersectional genetics to generate triple transgenic mice which restricted expression of 
transgenes to CCK+ cells45.  However, this approach labels all of the CCK neurons in the brain, 
making region-specific manipulation of CCK neurons challenging. Therefore, we felt that that 
the combination of recombinant viruses and CCK-Cre mouse lines was still the best approach 
but we still needed to increase the specificity of the virus. Therefore, in our approach to 
selectively target dentate CCK interneurons, we tested several serotypes of AAVs (AAV2, 
AAV5, AAV8) by injecting them into the hilus of CCK-Cre mice where the somata of the 
dentate CCK cells are located. As a result, we found that stereotaxic injection of properly 
titered AAV2-hSyn-DIO-hM3Dq-mCherry into the DG labeled hilar CCK interneurons 
without labeling the neighboring dentate granule cells and CA3 pyramidal cells (Figure 2-1: 
A-B). Moreover, dentate CCK interneurons labeled by AAV2-hM3Dq-mCherry were spatially 
restricted within the hilus throughout the dorsal-ventral axis (Figure 2-8: A). Next we used an 
established antibody against pro-CCK (Beinfeld, 1985) as a marker to validate the specificity 
and efficiency of CCK-Cre mice in targeting dentate CCK interneurons. We found that AAV2-
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DIO-hM3Dq-mCherry labeled ~70% of the total pro-CCK+ cells; and nearly 100% of the 
mCherry+ cells were pro-CCK+ (Figure 2-1: C-D). Importantly, almost all the mCherry+ cells 
were GABA+, indicating that CCK interneurons are GABAergic in nature (Figure 2-1: E-F). 
Activity-dependent neuropeptide release requires an important “priming” step in which release 
of Ca2+ from intracellular stores prepares large dense core vesicles (LDCVs) to fuse with the 
cellular membrane46. Therefore, we adopted a chemogenetic approach using CNO-activated 
Gq-DREADDs to induce endogenous CCK release. Gq signaling induces mobilization of Ca2+ 
from the intracellular stores, thus priming LDCVs for CCK release47. We validated the efficacy 
of chemogenetic activation of CCK interneurons via slice electrophysiology and calcium 
imaging. First, we recorded firing rates of CCK cells labeled with AAV2-DIO-hM3Dq-
mCherry upon bath application of clozapine N-oxide (CNO) in acute slices, and observed that 
CNO application increased the firing frequency of the CCK cells as compared to the baseline 
(Figure 2-1: G-I). Interestingly, dentate CCK interneurons exhibited distinct responses upon 
CNO application: some cells were quiet at the baseline, and CNO application depolarized them 
and increased their firing rate (Figure 2-1: G); while other cells were relatively active at the 
baseline, and CNO application increased their firing rate without significant baseline shift 
(Figure 2-1: H). These results highlight the heterogeneity of dentate CCK interneurons in 
response to activation. To confirm the effect of CNO-induced chemogenetic activation of CCK 
cells, we performed calcium imaging in dentate CCK cells by co-injecting AAVDJ-DIO-
GCaMP6s and AAV2-DIO-hM3Dq-mCherry to CCK-Cre mice (Figure 2-8: B). As a result, 
bath application of CNO led to increased Ca2+ signals in CCK cells, required for large dense 
core vesicles (LDCV) release. These results together confirmed the efficacy of chemogenetic 
activation of CCK interneurons. 
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Next we sought to examine the role of endogenous CCK release from dentate CCK 
interneurons in regulating the functional properties of rNSCs in acute brain slices. To examine 
the functional effect of endogenous CCK release on rNSCs at the circuit level, we generated 
double-transgenic CCK-Cre::Nestin-GFP mice. We injected AAV2-DIO-hM3Dq-mCherry 
into the DG of CCK-Cre::Nestin-GFP mice (Figure 2-1: J) to chemogenetically activate CCK 
interneurons and recorded the membrane potential (Vm) of the GFP+ rNSCs in acute brain 
slices upon bath application of CNO in artificial cerebrospinal fluid (ACSF). The purpose of 
this manipulation was to address the net circuit effect of dentate CCK interneurons on rNSCs 
with intact local circuit components. At baseline, rNSCs maintain an average Vm of -78.8 ± 
3.2 mV (Figure 2-1: N). Interestingly, chemogenetic activation of CCK interneurons 
depolarized rNSCs to -23.1 ± 7.2 mV (Figure 2-1: K-O). Furthermore, depolarization of rNSCs 
was abolished in the presence of the CCK2R antagonist YM022 (Figure 2-1: L-O). As 
CCK2Rs are typically members of the Gαq family of GPCRs, we also tested whether this was 
the case in rNSCs, and found that bath applied Gαq blocker YM254890 similarly abolished 
rNSC depolarization (Figure 2-1: M-O). These results suggest that rNSC depolarization upon 
chemogenetic activation of CCK interneurons is through CCK2R-mediated Gαq signaling, 
thus eliminating the possibility that co-release of GABA or glutamate from dentate CCK 
interneurons contribute to rNSC depolarization. 
 
CCK interneuron activity induced rNSC depolarization is mediated by a glutamatergic 
relay 
We sought to address whether CCK interneuron activity induced depolarization of 
rNSCs represents a direct effect on rNSCs from local CCK interneurons or an indirect effect 
on rNSCs through other niche components recruited by CCK interneuron activation. Recent 
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single-cell RNA-seq was unable to detect mRNAs for CCK2Rs in rNSCs18.To examine this 
further, we recorded Vm of Nestin-GFP+ rNSCs with bath application of nonsulfated 
cholecystokinin octapeptide (CCK8ns), the most abundant form of CCK in the brain and an 
agonist for CCK2Rs, in the presence of Tetrodotoxin (TTX), ionotropic GluR (iGluR) and 
group I metabotropic GluR (mGluR) blockers (APV+NBQX+AIDA), and GABAAR blocker 
(bicuculline)48. Our results showed that bath application of CCK8NS in the presence of TTX 
and various receptor blockers mentioned above did not alter the Vm of rNSCs (Figure 2-2: 
A,D,E). In contrast, bath application of CCK8ns without TTX and receptor blockers induced 
a prominent depolarization in rNSCs (Figure 2-2: B, D, E), which was abolished by CCK2R 
antagonist YM022 (Figure 2-2: C-E). These data together suggest an indirect interaction 
between CCK interneurons and rNSCs. 
To dissect the potential intermediates under conditions of 
neurotransmitter/neuropeptide release at endogenous CCK terminals, we returned to the 
chemogenetic model used in Figure 2-1: J. We were then able to record rNSCs upon CNO 
application in the presence of various combinations of GABAR or GluR blockers. In the 
presence of GABAAR blocker bicuculline, rNSCs exhibited a robust depolarization upon CNO 
application that was not significantly different from that recorded in ACSF (Figure 2-2: F, I, 
J), suggesting that interneuron-mediated GABAergic components do not contribute to the 
rNSC depolarization. Next we added NBQX (AMPAR blocker), APV (NMDAR blocker), and 
AIDA (group I mGluR blocker) in the bath in addition to bicuculline in order to block both 
iGluRs and group I mGluRs, as both iGluRs and group I mGluRs, when activated, increase 
neural excitability. As a result, the rNSC depolarization was completely abolished upon adding 
CNO (Figure 2-2: G, I, J), suggesting that glutamatergic components are necessary for CCK 
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interneuron mediated rNSC depolarization. Furthermore, we examined the contribution of 
iGluRs and group I mGluRs in mediating CCK interneuron induced rNSC depolarization. We 
recorded rNSCs in the presence of bicuculline+NBQX+APV or bicuculline+AIDA to isolate 
the contribution from iGluRs or group I mGluRs, respectively. As a result, under both 
recording conditions, we observed reduced depolarization magnitude in rNSCs (Figure 2-2: H, 
I) and percentage of responding rNSCs (Figure 2-2: J) upon chemogenetic activation of dentate 
CCK interneurons as compared to that in ACSF or bicuculline. The delay time to 
depolarization in rNSCs after CNO application varied from cell to cell and were not 
significantly different from each other (Figure 2-2: K). Together, these data suggest that CCK 
interneuron activity induced rNSC depolarization requires the activation of both iGluRs and 
group I mGluRs. 
Supporting the model of the interaction between CCK interneurons and rNSCs through 
GluRs in rNSCs, recent single-cell RNA-Seq data showed that rNSCs express mRNAs for 
AMPARs, NMDARs, and group I mGluRs18.  By conducting electrophysiological recordings 
of rNSCs, we confirmed the presence of functional iGluRs and group I mGluRs in rNSCs. 
Specifically, bath application of AMPA, NMDA, or DHPG in the presence of TTX led to 
depolarization in rNSCs (Figure 2-9), suggesting the presence of functional iGluRs and group 
I mGluRs in rNSCs. 
 
CCK interneuron stimulation reduces the activity of dentate glutamatergic neurons 
We sought to investigate the potential sources of the glutamatergic signaling onto 
rNSCs. The major neuronal glutamatergic sources are from the excitatory neurons in the DG, 
including granule cells (GCs) and mossy cells (MCs). Our recent work using electron 
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microscopy with immunolabeling has established that the “bushy heads” of the rNSCs wrap 
around the glutamatergic synapses formed between MCs and GCs35.  We first performed Ca2+ 
imaging in MCs and GCs to examine the functional interaction between CCK interneurons and 
local excitatory neurons. To record Ca2+ transients from dentate GCs and MCs upon activation 
of CCK interneurons, we injected a mixture of AAV2-hSyn-DIO-hM3Dq-mCherry and 
AAVDJ-CaMKII-GCaMP6f to the DG of CCK-Cre mice in order to label dentate CCK 
interneurons with hM3Dq and glutamatergic neurons with GCaMP6, respectively (Figure 2-3: 
A, B). These two viruses have been independently validated for specificity in labeling dentate 
CCK interneurons (Figure 2-1: C,D) and for MCs and GCs35.  Surprisingly, we observed a 
significant decrease of Ca2+ events in GCs (Figure 2-3: C-D) and MCs (Figure 2-3: E-F) upon 
CNO- induced chemogenetic activation of CCK interneurons. Interestingly, these inhibitory 
effects on GCs and MCs were abolished by bath application of GABAAR antagonist 
bicuculline (Figure 2-3: G, H, and Figure 2-10: A, E, C, G), and were actually significantly 
increased in granule cells, suggesting CCK interneuron activation leads to strong GABAergic 
signaling that may obscure an underlying excitatory component. Importantly, the frequency of 
the Ca2+ events remained largely unchanged in both GCs and MCs when CCK cells were 
activated in the presence of CCK2R blocker YM022 (Figure 2-3: I, J, and Figure 2-10). In 
addition to the frequency of the Ca2+ events, we also quantified the size of these Ca2+ events. 
We found that CNO-induced chemogenetic activation did not significantly change the size of 
the Ca2+ events in GCs, though there is trend toward a decrease (Figure 2-10: D), but 
significantly reduced the size of the Ca2+ events in MCs (Figure 2-10: H). Together, these 
results suggest that activation of CCK interneurons has the overall outcome of reducing Mossy 
Cell and Granule Cell activity through a CCK2R mediated mechanism. 
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As GCs and MCs are well known to be inhibited by local parvalbumin (PV) 
interneurons we sought to determine whether CCK activation of PV interneurons might be 
responsible for the GABAergic inhibition of local glutamatergic cells49,50. To record PV 
spiking upon activation of CCK interneurons, we injected a mixture of AAV2-hSyn-DIO-
hM3Dq-mCherry and AAV5-fDIO-YFP to the DG of double transgenic CCK-Cre::PV-FLP 
mice in order to activate dentate CCK interneurons with hM3Dq and visualize YFP+ PV cells 
(Figure 2-3: K, L). Interestingly, cell-attached recordings from PV interneurons revealed a 
significant increase in the spike rate, which was abolished in the presence of CCK2R antagonist 
YM022 (Figure 2-3: M, N). 
It is worth noting that bath application of bicuculline led to a significant increase of the 
Ca2+ events in GCs (but not MCs), suggesting that GCs receive stronger GABA inputs than 
MCs. Therefore, we sought to confirm whether GCs receive more synaptic GABA inputs upon 
activation of CCK interneurons. We injected CCK-Cre mice with AAV2-hSyn-DIO-hM3Dq-
mCherry and performed whole-cell recordings of GCs in acute brain slices (Figure 2-3: O, P). 
As a result, we observed four-fold increases in the frequency of spontaneous inhibitory 
postsynaptic currents (sIPSCs) during chemogenic activation of CCK cells (Figure 2-3: Q-T), 
and these sIPSCs were abolished by GABAAR antagonist bicuculline. Together, these data 
indicate that CCK interneuron activation induces a reduction in dentate excitatory neurons 






CCK interneuron activity induced rNSC depolarization requires dentate astrocytic 
intermediates 
Since the local glutamatergic neurons become inhibited during CCK activation, we 
sought to identify an alternative source of glutamate that could mediate depolarization of 
rNSCs. Ample evidence supports the view that Ca2+ elevation in astrocytes promotes release 
of gliotransmitter, including glutamate and D-serine which could potentially act on both 
iGluRs and group I mGluRs to depolarize rNSCs51–53. To determine if astrocytes serve as an 
intermediate in CCK induced depolarization of rNSCs, we interfered with astrocyte signaling 
by application of a commonly used glial-specific Krebs cycle inhibitor Fluorocitric acid 
(FC)54,55.  We injected CCK-Cre;:Nestin-GFP animals with AAV2-hSyn-DIO-hM3Dq-
mCherry in order to activate CCK cells and visualize rNSCs for patch recording as before 
(Figure 2-4: A). Strikingly, chemogenetic activation of dentate CCK cells failed to induce 
rNSC depolarization upon bath application of CNO when astrocyte signaling was disrupted by 
FC (Figure 2-4: B-D). Importantly, rNSCs retained their ability to depolarize by exogenous 
application of glutamate (Figure 2-4: E), suggesting that FC does not disrupt the machinery for 
rNSCs to receive glutamatergic signaling. 
Next we sought to address whether CCK interneuron activation is able to excite 
astrocytes by performing Ca2+ imaging in acute brain slices. We co-injected CCK-Cre mice 
with a combination of AAV2-hSyn-DIO-hM3Dq-mCherry and AAV2/5-GFAP-GCaMP6-
LCK (Figure 2-4: F) for Ca2+ imaging in astrocytes upon chemogenetic activation of dentate 
CCK cells. Confocal imaging confirmed expression of GCaMP6 in astrocytes adjacent to 
mCherry+ CCK neurons (Figure 2-4: G), thus providing morphological support for the 
potential interaction between these two cell types. Functionally, we observed a significant 
increase in astrocytic Ca2+ events upon chemogenetic activation of CCK cells (Figure 2-4: H, 
20 
 
I), which was abolished in the presence of CCK2R antagonist YM022 (Figure 2-4: J, K). Since 
GABA signaling has been shown to activate astrocytes and our study found PV neurons are 
activated by CCK neurons, we recorded Ca2+ signals of astrocytes in the presence of GABAA 
and GABAB receptor antagonists56. As a result, we still observed significant CNO-induced 
increases in Ca2+ events (Figure 2-4: L), suggesting that the GABA component does not play 
a major role in CCK-driven astrocyte activation. Furthermore, bath application of CCK peptide 
in the presence of TTX induced increased Ca2+ events in astrocytes (Figure 2-4: M), 
suggesting that CCK can directly act on astrocytes without the requirement of other neuronal 
intermediates. We also examined the integrity of activated astrocytes, and found that 
chemogenetic activation of CCK interneurons did not induce any changes in astrocyte 
morphology and glial fibrillary acidic protein (GFAP) expression in DIO-hM3D injected 
animals as compared to DIO-mCherry injected littermates (Figure 2-4: N, O). 
As chemogenetic activation of CCK cells excites astrocytes by increasing their Ca2+ 
transients, we attempted to quench the astrocytic Ca2+ signaling network through infusion of 
the Ca2+ chelator BAPTA into the astrocytes using a patch pipette and assay whether this 
would interfere with CCK induced depolarization of rNSCs54. We first confirmed that we were 
able to efficiently label astrocytes with AAV8-GFAP-mCherry for patch infusion of BAPTA 
concurrent with AAV2-DIO-hM3Dq-mCherry expression in CCK cells (Figure 2-11: A, B). 
We then confirmed that infusing BAPTA into an mCherry+ astrocyte is sufficient to interfere 
with Ca2+ signaling in the astrocytic network (Figure 2-11: C-F). Finally, we injected CCK-
Cre::Nestin-GFP mice with AAV2-hSyn-DIO-hM3Dq-mCherry and AAV2/5-GFAP-
mCherry in order to disrupt the astrocytic Ca2+ network while recording Vm of rNSCs upon 
chemogenetic activation of CCK cells (Figure 2-4: P, Q). Interestingly, disrupting the astrocyte 
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Ca2+ signaling network abolished rNSC depolarization induced by CCK interneuron 
activation (Figure 2-4: R, S). Importantly, rNSCs remained responsive to bath application of 
glutamate after astrocyte BAPTA infusions (Figure 2-4: T), suggesting that BAPTA treatment 
of astrocytes does not disrupt the machinery for rNSCs to receive glutamatergic signaling. To 
further confirm the role of astrocytes in mediating rNSC depolarization, we injected AAV2/5-
GFAP-hM3Dq-mCherry to Nestin-GFP mice in order to directly activate astrocytes and record 
the Vm of rNSCs. (Figure 2-11: G, H). We found that chemogenetic stimulation of hilar 
astrocytes alone was sufficient to induce depolarization of rNSCs (Figure 2-11: I, J). Together, 
these results indicate that astrocytes are the predominant intermediate that enable rNSC 
depolarization during CCK interneuron activation, presumably via release of gliotransmitters 
(such as glutamate and D-serine) and activation of GluRs on rNSCs. 
 
CCK interneuron stimulation promotes proliferation of rNSCs via MAPK/ERK 
signaling and subsequent hippocampal neurogenesis 
Vm has been implicated as a functional determinant of cell behaviors of non-neuronal 
cells, such as proliferation and differentiation of embryonic stem cells57. Quiescent cells are 
strongly polarized with a hyperpolarized Vm, whereas proliferation events are frequently 
accompanied by membrane depolarization58.  Transduction of extracellular niche signals 
activates cell surface receptors that in turn triggers a signaling cascade of intracellular 
regulatory mechanisms that control activation and quiescence states in adult rNSCs. It has been 
shown that both NMDARs and group I mGluRs can activate mitogen-activated protein kinase/ 
extracellular-signal-regulated kinase 1/2 (MAPK/ERK1/2) pathways via distinct upstream 
effectors59.  We therefore sought to determine whether stimulation of local CCK interneurons 
results in increased phospho-ERK (pERK) signaling in rNSCs. To test this, we took an in vivo 
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chemogenetic approach to stimulate CCK interneuron activity using excitatory DREADDs. 
We examined pERK expression in rNSCs from AAV2-DIO-hM3Dq or AAV2-DIO-mCherry 
injected CCK-Cre mice 80 minutes after CNO intraperitoneal injection (Figure 2-5: A). As a 
result, we observed a significant increase in the density of pERK+ rNSCs upon chemogenetic 
activation of CCK interneurons in AAV2-DIO-hM3Dq injected mice compared to AAV2-
DIO-mCherry injected mice at 80 min post CNO injection (Figure 2-5: B, C). Since ERK 
phosphorylation occurs within minutes after activation of CCK2R, these results suggest an 
indirect mechanism of activating the ERK pathway in rNSCs upon CCK interneuron 
activation. As a mitogen-activated protein kinase (MAPK), ERK has emerged as a central 
regulator of cell proliferation through promotion of the G1/S cell cycle progression60,61.  
Specifically, activation of ERK signaling drives hyper-phosphorylation of retinoblastoma 
protein (RB), thus releasing RB’s inhibition of the E2F family of transcription factors which 
are then free to activate transcription of genes required for the G1/S transition62.  To address 
whether hyper-phosphorylated RB (pRB) mediates CCK interneuron activity dependent rNSC 
activation, we examined pRB expression in rNSCs 5 hours after CNO injection (Figure 2-5: 
D). As a result, we observed a significant increase in the density of pRB+ rNSCs as compared 
to the sham controls (Figure 2-5: E, F). 
Our electrophysiology data showed that dentate CCK interneuron activation induced a 
depolarization of the rNSCs, therefore, we hypothesized that activation of CCK interneurons 
promotes rNSC activation. To test this hypothesis, we injected AAV2-DIO-hM3Dq-mCherry 
into the DG of CCK-Cre mice to induce expression of hM3Dq in CCK interneurons (Figure 
2-5: G). At 2 weeks after viral injection, we then induced activation of dentate CCK 
interneurons for 4 days via CNO drinking water, followed by 4 intraperitoneal (IP) injections 
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of EdU (every 2 hours) to label dividing cells (Figure 2-5: H). We assessed EdU incorporation 
by counting EdU+ Nestin+ rNSCs with radial processes (Figure 2-5: I). Stereological analysis 
showed that chemogenetic activation of local CCK interneurons led to a significant increase in 
the density and percentage of EdU+ rNSCs (Figure 2-5: J, K) compared to the sham treatment 
group without altering the Nestin+ stem cell pool (Figure 2-5: L). As rNSCs are thought to 
give rise to transient amplifying progenitors, we examined the density of EdU+ newborn 
progeny, and observed a significant increase of EdU incorporation upon chemogenetic 
activation of CCK interneurons (Figure 2-5: M). These results suggest that dentate CCK 
interneuron activation promotes adult rNSC activation and neural progenitor proliferation. 
We next sought to determine the long-term effects of CCK stimulation on neurogenesis 
and the stem cell pool. We injected animals with AAV2-DIO-hM3Dq-mCherry or a sham 
control (as with previous experiments), and then administered CNO in drinking water for a 
period of 3 weeks (Figure 2-5: N). In order to determine the effect of long-term CCK 
interneuron activation on neurogenesis, we wanted to quantify the change in production of 
doublecortin (DCX)+ immature neurons in the DG. However, DCX+ immature neurons are 
very dense in the DG and so are difficult to quantify using our normal stereological 
quantifications. Therefore, we quantified the total volume of DCX+ cells in hilus using 
volumetric analysis. This method revealed a significant increase in the total volume of DCX+ 
cells after prolonged chemogenetic activation of CCK interneurons. However, this increased 
production of newborn neurons does not result in exhaustion of the rNSC pool (Figure 2-5: O-
Q). Taken together, these results suggest that CCK interneuron stimulation promotes rNSC 
activation via MAPK/ERK signaling and activation of G1/S cell cycle regulators, resulting in 
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increased proliferation of newborn progeny and production of newborn neurons without 
depleting the rNSC pool. 
 
Suppressing CCK release decreases proliferation of rNSCs and newborn progeny 
Chemogenetic activation of dentate CCK interneurons may not fully mimic 
endogenous activity patterns in vivo, therefore, we took a loss-of-function approach to address 
whether CCK peptide release is necessary in the regulation of rNSC activation. To examine 
the role of endogenous CCK activity in regulating rNSCs without disrupting the GABA-
signaling component of dentate CCK interneurons, we used a viral-based approach in which 
synthesis and release of CCK was suppressed using a virally delivered, validated shRNA 
targeting CCK (shCCK)63.  We injected AAV-shCCK-eGFP or AAV-shScrambled-eGFP to 
BL6 mice (Figure 2-6: A), and analyzed the efficiency of shCCK by western blot and 
immunostaining one month after viral injection (Figure 2-6: B). Western blot analysis showed 
a significant knockdown of CCK protein in hippocampal tissues from mice injected with AAV-
shCCK-eGFP, as compared to the mice injected with AAV-shScrambled-eGFP (Figure 2-6: 
C-D). Furthermore, immunostaining with a pro-CCK antibody of tissue from injected with 
shCCK further confirmed efficient knockdown of CCK in the hilar CCK cells. Normally bright 
CCK signal in hilar cells was dramatically reduced in mice injected with shCCK as compared 
to mice injected with the control virus (Figure 2-6: E). To examine the functional effects of 
reduced CCK release on the key behavior of rNSCs, we labeled dividing cells through 4 EdU 
injections separated by 2-hour intervals and examined the activation of rNSCs and proliferation 
of newborn progeny (Figure 2-6: B). Our stereological quantification showed that suppression 
of CCK synthesis led to a significant decrease in the density and percentage of EdU+ Nestin+ 
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rNSCs (Figure 2-6: F, G) and total EdU+ neural progenitors (Figure 2-6: H) compared to the 
sham treatment group. Interestingly, inhibition of CCK synthesis did not alter the Nestin+ 
rNSC pool (Figure 2-6: I). Along with the data from chemogenetic activation of dentate CCK 
interneurons, these results suggest that CCK activity bidirectionally regulates the proliferation 
of rNSCs and newborn progeny. 
 
Suppressing CCK release induces reactive astrocytes and neuroinflammation 
mimicking AD pathology 
Our findings that astrocytes serve as a critical intermediate in CCK interneuron 
activity- induced depolarization and proliferation of rNSCs suggest that increased CCK release 
may induce a trophic state of astrocytes characterized by increased Ca2+ transients and release 
of gliotransmitters that in turn promote hippocampal neurogenesis. Therefore, we wondered 
whether reduced CCK release contributes to an adverse state of astrocytes. To address this 
question, we first examined GFAP expression in the dentate astrocytes by quantifying GFAP 
immunofluorescence in mice injected with AAV-shCCK or AAV-shScrambled. GFAP gene 
expression in astrocytes has been established as a standard marker for astrocyte reactivity64.  
Strikingly, we found significantly increased volume of GFAP immunofluorescence in AAV-
shCCK injected mice as compared to AAV-shScrambled injected controls (Figure 2-7: A, B), 
suggesting that reduced CCK release induces astrocyte reactivity. 
To further confirm the reactive astrocyte phenotype induced by reduced CCK release, 
we performed RNA-Seq of the dentate gyri micro-dissected from AAV-shCCK or AAV-
shScrambled injected mice (Figure 2-12: A, GEO Accession: GSE137052). Our RNA-Seq 
analysis identified 496 differentially expressed genes (DEGs), including 144 significantly 
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downregulated and 352 significantly upregulated transcripts (Figure 2-7C). Recent 
advancements in gene profiling of reactive astrocytes has generated rich information on the 
gene signatures for the unique states of reactive astrocytes65,66. We therefore compared our 
RNA-Seq data with recently published data sets of genes that have been identified to be 
upregulated in reactive astrocytes induced by neuroinflammation65.  We found that 17 of these 
reactive-astrocyte associated genes were differentially expressed in the DGs of AAV-shCCK 
injected mice compared to AAV-shScrambled injected controls (Figure 2-7: D, Table 2-2). 
These DEGs include standard reactive astrocyte genes (PAN: 8/17), such as GFAP and 
Vimentin, A1-reactive genes associated with neuroinflammation (A1: 7/17), such as C3 and 
Cxcl10, and A2-reactive genes associated with ischemia (A2: 2/17). These data suggest that 
reduced CCK release induces astrocyte reactivity, especially A1 neuroinflammatory reactive 
astrocytes. Supporting this notion, our gene ontology analysis revealed enrichment of several 
classes of immune processes and inflammatory responses (Figure 2-7: E, Figure 2-12: B). 
In our gene ontology analysis of 492 DEGs, we identified a network of 21 DEGs 
involved in negative regulation of cell proliferation (Figure 2-7: E, F, Figure 2-12: C, Table 
2-1). Since reactive astrocytes usually exhibit a low-moderate level of proliferation in the 
contexts of neuroinflammation and AD, we speculated that this gene network for negative cell 
proliferation is neurogenesis related, which is also supported by our functional evidence that 
reduced CCK release decreases the proliferation of rNSCs and newborn progeny64. To confirm 
that these DEGs are indeed expressed in rNSCs, we cross-referenced these DEGs to a 
published gene profile for Nestin+ adult neural precursor cells in the DG, and found that the 
majority of these DEGs are indeed highly expressed in Nestin+ rNSCs (Figure 2-7: G)18. These 
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results suggest that reduced CCK release induces astrocyte reactivity that in turn contributes 
to decreased proliferation of rNSCs and newborn progeny. 
As reactive astrocytes and neuroinflammation are strongly associated with 
neuropathological conditions, we wondered whether CCK levels were altered in these 
conditions. Given that ample studies have reported astrogliosis and neuroinflammation in AD, 
we wanted to examine if CCK expression is also be decreased in AD and thus could be 
contributing to these pathologies67. Toward this direction, we employed a widely used AD 
mouse model with accelerated AD pathology, 5xFAD (C57BL6), which harbors human APP 
and PS1 transgenes.  It has been shown that 5xFAD mice exhibit significant levels of 
astrogliosis, and we confirmed this phenotype in 8-month old 5xFAD mice through 
quantification of GFAP immunofluorescence (Figure 2-7: H, I)68. As we previously 
demonstrated that reduced CCK expression in the DG results in increased astrocyte reactivity 
(Figure 2-7: A-B), we wondered whether the increased level of astrocyte reactivity observed 
in AD mice correlates with reduced levels of CCK in the DG of AD mice. To answer this 
question, we performed western blots on whole cell lysates of micro-dissected DG tissues from 
5xFAD mice and their age-matched littermates and found decreased expression of CCK in 
5xFAD mice across ages as compared to their littermate controls (Figure 2-7: J, K). 
Furthermore, stereological analysis revealed a significant decrease in the proliferation of 
rNSCs and newborn progeny of 8-month 5xFAD mice (Figure 2-7: L-N), reminiscent of that 
in shCCK injected BL6 mice (Figure 2-6: F-I). Taken together, these results suggest that 
reduced CCK expression in the DG of AD mice correlates with increased astrogliosis and 
decreased proliferation of rNSCs and newborn progeny. This would suggest that reduced CCK 
levels are either a contribute to the onset of AD or, more likely, are lowered as a result of AD 
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pathology and this then further increases the severity of the disease symptoms associated with 
AD. 
 
Materials and methods 
Animals: 
Single or double transgenic young adult mice (6-12 weeks, males and females) were 
used and randomly assigned to experimental groups. C57BL/6J (RRID:IMSR_JAX:000664), 
CCK-IRES-Cre (B6N.Cg-Ccktm1.1(cre)Zjh/J; RRID:IMSR_JAX:019021), PV-Flp (B6.Cg-
Pvalbtm4.1(flpo)Hze/J; RRID:IMSR_JAX:022730), and 5xFAD mice (B6.Cg-
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/Mmjax; RRID:MMRRC_034848-JAX) 
were obtained from Jackson laboratory; Nestin-GFP mice were obtained from Dr. Grigori 
Enikolopov at Stony Brook University. Animals were group housed and bred in a dedicated 
husbandry facility with 12/12 light-dark cycles with food and water ad libitum and recieved 
veterinary supervision. Animals subjected to surgical procedures were moved to a satellite 
housing facility for recovery with the same light-dark cycle. No immune deficiencies or other 
health problems were observed in these lines, and all animals were experimentally and drug 
naive before use. Electrophysiology or calcium imaging experiments were typically performed 
on animals at 2-4 months of age. Some animals for AD studies were used at 3-8 months of age. 
All animal procedures followed NIH Guide for the Care and Use of Laboratory Animals and 
were approved by Institutional Animal Care and Use Committee at the University of North 





In brief, mice were anesthetized under 1-2% isoflurane in oxygen at 0.6-0.8 LPM flow 
rate. Adeno-associated virus (AAV) vectors were injected under stereotaxic control to the DG 
using the following coordinate: AP -2.0 mm, ML +/- 1.5 mm, DV -2.3 mm from Bregma, with 
microsyringe (Hamilton, 33GA) and microinjection pump (Hamilton) at a speed of 75nl/min. 
The needle then remained in place for 5 min before being withdrawn. Mice were allowed to 
recover for 2 weeks from the surgery before in vivo or in vitro experiments. For in vivo 
DREADD experiments, CCK-IRES-Cre mice were injected with 300 nL AAV2-hSyn-DIO-
hM3Dq-mCherry or AAV2-hSyn-DIO-mCherry (Addgene/UNC Vector Core) bilaterally into 
the DG. Several measures were taken to increase the specificity of viral labeling by restricting 
the spread of the virus to the hilus by: (1) reducing flow rate to 75 nL/min (2) packaging the 
DREADD in AAV2, which doesn’t spread as far from the injection site as other serotypes do, 
and (3) diluting the virus to a titer of 1.08 x 1011 viral genomes/mL. For EdU/proliferation 
quantifications, CNO was dissolved in drinking water at a concentration of 5mg/200mL for 4 
days. CNO was from NIH as part of the Rapid Access to investigative Drug Program funded 
by National Institute of Neurological Disorders and Stroke (NINDS). On the last day, animals 
were given IP injections of EdU (40 mg/kg, Carbosynth) for 4 times at 2-hour intervals. 
Animals were perfused 2 hours after the last injections of EdU. For quantifications of phospho-
ERK and phospho-RB in rNSCs, CNO was administered via a single IP injection (5 mg/kg) 
and animals were then perfused either 80 minutes (phospho-ERK) or 5 hours (phospho-RB) 
later. For in vivo shRNA experiments, mice were injected with 1uL of either AAV5-CMV-
shCCK-eGFP or AAV5-CMV-shScrambled-eGFP (AAV vectors from Ralph DiLeone, Yale 
Univ.; and short-hairpin sequences were adapted from published work(Arey et al., 2014)). 
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After 4 weeks, animals were given IP injections of EdU and perfused as previously described. 
For slice recording, viral injections were conducted similarly. Additional AAV vectors 
including AAV8-CaMKII-hM4Di-mCherry, AAV8-CaMKII-hM3Dq-mCherry (Addgene) 
and AAVDJ-EF1α-DIO-GCaMP6s, AAVDJ-CaMKII-GCaMP6s (DREADD viruses from 
Addgene; GCaMP virus from Dr. Garret Stuber, Univ. Washington), AAV5-EF1a-fDIO-
EYFP-WPRE (UNC Vector Core), AAV8-GFAP104-mCherry (UNC Vector Core), AAV2/5-
GFAP-GCaMP6-LCK (Addgene) were injected into the DG of adult mice for different 
experiments. Mice with viral expression outside the region of interest (DG) were excluded 
from tissue processing and further analysis. 
 
Electrophysiological recordings:  
Adult mice were used for slice preparation and electrophysiological recording 2-4 
weeks after viral injection. No specific replication designs were used, but multiple animals 
were used as indicated in the figure legends. Sample size estimation was based on previous 
publications and power analysis. Mice with viral expression outside the region of interest (DG) 
were excluded from further analysis. 
Animals were anesthetized under isoflurane and briefly perfused intracardially with 10 
mL of ice-cold NMDG solution(Ting et al., 2014) containing (in mM): 92 NMDG, 30 
NaHCO3, 25 glucose, 20 HEPES, 10 MgSO4, 5 sodium ascorbate, 3 sodium pyruvate, 2.5 
KCl, 2 thiourea, 1.25 NaH2PO4, 0.5 CaCl2 (pH 7.24, 300 mOsm, bubbled with 95% O2 and 
5% CO2). The brains were then quickly removed into additional ice-cold NMDG solution for 
slicing. Transverse slices were cut using a Leica VT1200S vibratome at 280 μm thickness, and 
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warmed to 36°C for 10 min. Slices were transferred to room temperature (22–24°C) HEPES 
holding solution (Ting et al., 2014) containing (in mM): 92 NaCl, 30 NaHCO3, 25 glucose, 20 
HEPES, 5 sodium ascorbate, 3 sodium pyruvate, 2.5 KCl, 2 thiourea, 2 MgSO4, 2 CaCl2, 1.25 
NaH2PO4, (pH 7.24, 300 mOsm, bubbled with 95% O2 and 5% CO2) for 1 - 2 hr. Solutions 
intended for use with CCK recordings, PV recordings, GC recordings or for calcium imaging 
also contained 12 mM N-acetyl-L-cysteine in the NMDG and HEPES solutions to improve 
glutathione synthesis (Ting et al., 2014). 
 Whole-cell electrophysiological recordings were obtained at 22–24°C in ACSF 
containing (in mM): 125 NaCl, 26 NaHCO3, 20 glucose, 2.5 KCl, 2 CaCl2, 1.3 MgCl2, 1.25 
NaH2PO4, (pH 7.24, 300 mOsm, bubbled with 95% O2 and 5% CO2) on a Scientifica 
SliceScope. GFP+ neural stem cells within the sub-granule zone,  or hilar mCherry+ CCK 
interneurons were visualized by DIC and fluorescence microscopy with a 40X water-dipping 
objective (LUMPlanFL N, 0.8; Olympus). rNSC identity of Nestin-GFP+ cells were confirmed 
by stereotypical type-1 responses to current pulses (non-rectifying, high-resistance). 
Microelectrodes (3–6 MΩ) were pulled from 1.5 mm diameter borosilicate glass capillaries 
(WPI) and filled with potassium based internal solution containing (in mM): 130 K-gluconate, 
20 HEPES, 4 MgCl2, 4 Na2-ATP, 2 NaCl, 0.5 EGTA, 0.4 Na-GTP (pH 7.24, 310 mOsm).  
Cell-attached recordings from YFP+ parvalbumin neurons were made by forming ≥ 
200 MOhm resistance seals using similar microelectrodes filled with filtered ACSF and no 
applied holding voltage.  
Spontaneous IPSCs from GCs were made by whole-cell recordings of non-fluorescent 
mature granule cells identified by DIC microscopy in the mid to outer Granule Cell Layer 
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(GCL) using a high-Cl internal solution containing (in mM): 140 KCl, 10 EGTA, 8 HEPES, 5 
QX-314, 2 Mg2-ATP (pH 7.3, 310 mOsm). 
BAPTA-filling of astrocytes was made in mCherry+ hilar astrocytes using a K-BAPTA 
internal solution containing (in mM): 70 sucrose, 50 K-gluconate, 20 K4-BAPTA, 10 HEPES, 
4 MgCl2, 4 Na2-ATP, 2 NaCl, 0.5 EGTA, 0.4 Na-GTP (pH 7.24, 310 mOsm). Internal solution 
was permitted to intracellularly perfuse the astrocyte for 20 minutes through a patch pipette in 
whole-cell configuration. 
Slices treated with FC (100 μM) were preincubated for 1 hour in bubbled ACSF 
containing the drug before recording, and remained in FC-ACSF during patch-recording. 
Data were collected using a Multiclamp 700B amplifier and digitized with a DigiData 
1440A (Axon Instruments) at 10 kHz using pClamp10 software. The whole-cell patch-clamp 
configuration was employed in current-clamp mode (with I = 0) to freely monitor membrane 
potential changes. Unstable whole-cell recordings (monitored by membrane test pulse) were 
excluded from analysis. 
Pharmacological agents (Tocris) were used at the following final concentrations in the 
bath as indicated: bicuculline (50 μM), NBQX (10 μM), APV (100 μM), TTX (1 μM), AIDA 
(100 μM), AMPA (1 mM), NMDA (1 mM), DHPG (200 μM), CCK8ns (300 nM), YM022 (1 
μM). CNO (obtained from NIH) was bath applied at 10 μM. YM254890 (5 μM), was purchased 
from Focus Biomolecules. All other chemicals, including L-glutamic acid (1 mM), and DL-






AAV-mediated DIO-GCaMP6s was selectively expressed in CCK-Cre mice, by AAV-
mediated expression of GFAP-GCaMP6-LCK,  or by CaMKII driven expression of GCaMP6f 
in dentate mossy cells and granule cells or in astrocytes. Acute brain slices were prepared and 
observed as for electrophysiology. A CoolLED pE-100 at 470 nm was used for excitation, and 
GCaMP fluorescence was acquired through a standard GFP filter cube and captured with an 
Optimos sCMOS camera (Q-Imaging), using Micro Manager acquisition software. Image 
sequences were acquired at 100-500 ms frame rates with 5-7 focal-plane sections. Imaging 
sessions of mossy cells, granule cells, or astrocytes were paused for 10 minutes at episodes of 




Following anesthetization, the hippocampus was dissected out from the whole brain 
and flash frozen in liquid nitrogen. Tissue was then lysed in RIPA buffer and homogenized 
with a dounce tissue grinder. This lysate was then used to perform a standard western blot with 
anti-proCCK (rabbit, 1:500) and anti-GAPDH (rabbit 1:1000) antibodies. Fluorescent or HRP-
conjugated secondary antibodies were then used to label both CCK and GAPDH protein bands. 
Fluorescent signal from the fluorescently labelled secondary antibodies could then be directly 
quantified while chemiluminescent substrate (Pierce) was required to produce 
chemiluminescent signal from the HRP conjugated secondary antibodies.  Fluorescent signal 
34 
 
was quantified using an Odyssey Imager and chemiluminescent signal was quantified using a 
ChemiDoc (BioRad). Densitometry analysis of signal was performed in ImageJ. 
 
Tissue process and Immunohistochemistry 
Mice were anesthetized with a mixture of ketamine and xylazine (100 mg/kg and 10 
mg/kg respectively) until no longer responsive to toe pinch. Brains were fixed via aortic arch 
perfusion of ice-cold 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) at pH 
7.4. Brains were collected and post-fixed in 4% PFA overnight, followed by 30% sucrose in 
PBS for 2-3 days. Brains were sectioned into 40 μm coronal sections with a microtome and 
stored in cryoprotectant solution containing 30% sucrose, 30% ethylene glycol in 0.1M 
phosphate buffer. 
To label proliferating cells, sections from mice injected with EdU were first rinsed in 
Tris-buffered saline (TBS) and then 0.05% Triton X-100 in TBS, followed by permeabilization 
in 0.5% Triton X-100 in TBS for 30 min. Sections were then incubated in click reaction buffer 
(0.1 M Tris, 0.5–1mM CuSO4, 30µM 488 Alexa azide (A10266, Invitrogen), and 50–100 mM 
ascorbic acid) for 1 hour for EdU labelling. Tissue was then rinsed 4-6X in 0.05% Triton X-
100 in TBS. 
For immunostaining, sections were first rinsed in TBS and then 0.05% Triton X-100 in 
TBS, followed by incubation in 0.5% Triton X-100 in TBS for 30 min (this step was omitted 
if tissue had already undergone the click reaction and so was already permeabilized). Sections 
were then incubated in blocking buffer (5% donkey serum in 0.05% Triton X-100 in TBS) for 
30-60 min followed by incubation in primary antibody (primary antibody + 5% donkey serum 
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diluted in 0.05% Triton X-100 in TBS). The following primary antibodies were incubated with 
tissue at 4C overnight: rat anti-mCherry (1:1000, Invitrogen), rabbit anti-GABA (1:500, 
Sigma), chicken anti-Nestin (1:250, Aves), rabbit anti-phospho RB (1:500, Cell Signaling), 
mouse anti-GFAP (1:500, Millipore), goat anti-DCX (1:500, SCBT), and goat anti-GFP 
(1:500, Rockland).  Rabbit anti-proCCK (1:500, a gift from Margery Beinfeld) was incubated 
for 48 hours at room temperature. Mouse anti-CCK8 (1:500, no. 9303 CURE) and anti 
phospho-ERK (1:100, Cell Signaling) were incubated for 72 hours at 4C. The sections were 
then rinsed with 0.05% Triton X-100 in TBS and incubated in secondary antibody (secondary 
antibody + 5% donkey serum diluted in 0.05% Triton X-100 in TBS) at room temperature (RT) 
for 2 hours followed by additional rinsing in 0.05% Triton X-100 in TBS. All the brain sections 
were mounted in an aqueous medium. 
Antigen retrieval is required for immunostaining with Nestin, phospho-ERK, and 
phospho-RB. Sections requiring antigen retrieval were first mounted onto charged slides and 
incubated in a beaker containing 0.1M citrate buffer and kept at between 92 - 95°C for a period 
of 7 mins under constant stirring. Slides then remained in citrate buffer after being removed 
from heat source and put on ice to cool down to room temperature. Sections then underwent 
permeabilization and blocking as previously described. 
 
Quantification and statistical analysis 
Electrophysiological quantification  
Electrophysiology traces were analyzed using a combination of the NeuroMatic 
package (Rothman and Silver, 2018) and custom built analysis routines, written for Igor Pro 
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(Wavemetrics). Resting Vm was reported for sample traces throughout the figures. 
Depolarization magnitudes were computed by averaging several minutes of baseline activity, 
subtracted from the smoothed peak membrane potential during drug application. Responding 
cells were considered as those that depolarized by ≥ 10 mV. Cells that depolarized too suddenly 
(within less than 2 minutes) were not included for analysis, as it may reflect unexpected loss 
of whole-cell configuration. 
Calculations of delay time were accomplished by fitting the membrane potential data 
from responding rNSCs to a Sigmoid function and drawing a tangent line at the midpoint of 
inflection. The intersection of the tangent line with the baseline level marked the initiation time 
of depolarization. The difference in time between CNO application and the intersection point 
determined the reported delay time.  
Spike counting and sIPSC detection were performed by semi-automated threshold 
detection and additional timing/level parameters in NeuroMatic analysis package(Rothman 
and Silver, 2018) in Igor Pro, and manually reviewed for accuracy. Non-typical events and any 
recording artifacts were excluded from analysis. Fold change in spiking occasionally was 
determined as infinite (inf) when zero spikes were detected at baseline. 
 
Calcium event analysis  
Ca2+ fluorescent signals were analyzed using hand-drawn ROIs in NIH ImageJ 
software and computed using custom procedures written in Igor Pro (Wavemetrics). The 
change in calcium signal was determined from surround subtracted regions of interest at the 
best focal plane for each cell, and converted into ΔF/F0 values using a running F0(Jia et al., 
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2011). Quantification of calcium event frequency was determined using peak detection 
algorithms and manual thresholding in Igor Pro. Sample calcium traces presented in the figures 
originate from the same cell in both the baseline and experimental condition. 
 
Stereological quantification 
Coronal sections through the entire hippocampus were collected in a serial order. Tiled 
images were acquired with an Olympus FLUOVIEW1000/Zeiss, or LSM780/Zeiss, or 
LSM710 confocal microscopes, using either 40x Oil (Olympus and Zeiss LSM780) or 20X 
(Zeiss LSM710) objectives, XY-resolution 0.4975 μm/pixel, and Z-resolution 1.0 µm/slice. 
Images were stitched using either Olympus FluoView or Zeiss ZEN imaging software.  All 
positive cell type marker quantifications were done manually throughout Z-stacks using Image 
J with the exception of DCX+ and GFAP+ cells.  Due to their high density, it is difficult to 
accurately identify individual DCX+ and GFAP+ cells and so DCX+ volume and GFAP+ 
volume were quantified using Imaris volumetric analysis.  DCX+ volume and GFAP+ volume 
were then normalized to the volume of their respective region of interest (ROI) (granule cell 
layer for the DCX+ quantification and the hilus for the GFAP+ quantification).  Slide identities 
were blinded during quantification to avoid bias. 
 
Microdissection of the dentate gyrus 
2 months after unilateral injection of 8 week-old, wild-type, C57BL/6J mice with either 
AAV5-shScrambled-eGFP or AAV5-shCCK-eGFP, mice were anesthetized using 5% 
isoflurane and sacrificed by decapitation.  The whole brain was then removed from the skull 
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and immediately placed in cold PBS.  Still in cold PBS, the brain was then bisected, and the 
dentate gyrus (DG) was then dissected out from the injected hemisphere.  DGs from each 
hemisphere were then placed in RNAlater Stabilization Solution (Thermo Fisher). 
 
RNASeq library prep and analysis 
Total RNA was extracted from fresh DG using TRIzol Reagent (Invitrogen) and Direct-
zol RNA Mini Prep kit (Zymo Research) according to the manufacturer’s instructions. Bulk 
mRNA-seq libraries were generated from triplicated samples per condition by Novogene. An 
Agilent 2100 BioAnalyzer and a DNA1000 kit (Agilent) were used to quantify amplified 
cDNA and to control the quality of the libraries. Illumina HiSeq4000 was used to perform 150-
cycle pair-end sequencing. Image processing and sequence extraction were performed using 
the standard Illumina pipeline. Paired-end reads were first aligned to mouse genome assembly 
and transcriptome annotations (mm9) by Tophat v2.1.1 with default settings. The numbers of 
mapped reads for each sample can be found in Table S2.  FPKM (fragments per kilobase of 
transcript per million mapped reads) values were calculated by Cufflinks v2.2.1.  Pairwise 
comparison between shCCK and shScrambled conditions were performed to detect 
differentially expressed (DE) genes using Cuffdiff v2.2.1.  DE genes are defined as those with 
q-value less than 0.05. Gene ontology (GO) analyses on biological processes were performed 
by the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8.  To 
identify significantly enriched DIRECT GO terms, a Benjamini–Hochberg procedure was used 
to control the false discovery rate (FDR) at 0.05. KEGG pathway enrichment analyses were 
performed by the WEB-based Gene SeT AnaLysis Toolkit (WebGestalt) update 2019 with 
adjusted p-value no greater than 0.05. The functional association networks were generated 
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Mice from both sexes were used for all experiments, and no other covariates were 
identified. Two-tailed unpaired Student’s t-test was used to examine the difference by using 
Graphpad Prism (Graphpad Software). Test for normality were not performed. For all 
experimental results, “n” represents the number of animals used unless otherwise specified and 
is reported in figure legends. All measurements are from distinct samples and were not repeated 
measurements. Data throughout are presented as mean ± standard deviation (SD) or mean ± 
standard error of the mean (SEM) as reported in the figure legends. Significance was 
determined based on p< 0.05 and displayed in the figures as: ns not significant, * p < 0.05, ** 
p< 0.01, *** p < 0.001, **** p < 0.0001.  
Statistics for electrophysiology were calculated using two-sample tests in Igor Pro 
(Wavemetrics), and were checked for randomness and equal variances.  Data were presented 
as means ± SEM. p values from Student’s T-Test are reported in the figure legends. n indicated 
number of cells recorded. The number of animals used was also reported in figure legends.  
Statistics for calcium imaging were calculated using two-sample tests in Igor Pro, and 
were checked for randomness and equal variances.  Data were presented as means ± SEM. p 
values from Paired Student’s T-Test are reported in the figure legends. n indicated number of 




DATA AND CODE AVAILABILITY  
RNA-seq data reported in this paper have been submitted to Gene Expression Omnibus 





Figure 2-1: Activation of local CCK interneurons induces a robust depolarization in 
rNSCs through a CCK2R mediated signaling mechanism.   
A, Bilateral injection scheme for labeling (AAV2-hSyn-DIO-mCherry) or chemogenetic 
activation (AAV2-hSyn-DIO-hM3Dq-mCherry) of CCK interneurons in the DG of adult 
CCK-Cre mice.  B, Confocal images of AAV2, AAV5, or AAV8 expression of DIO-
hM3Dq-mCherry at identical coordinates and equivalent viral titers. Scale bar 100 µm. C, 
top: Confocal image of the DG showing viral expression of mCherry (red) in hilar CCK 
interneurons (scale bar: 100 µm) after injection of AAV2-hSyn-DIO-mCherry.  (DAPI: blue, 
proCCK: green, mCherry: red).  C, bottom: Higher magnification images of (C, top) showing 
co-localization of mCherry with proCCK+ hilar interneurons. Scale bar: 50 µm.  D, 
Quantification of both the specificity (left) and efficiency (right) of DREADD expression in  
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(Figure 2-1 continued) 
hilar CCK interneurons after injection of AAV2-hSyn-DIO-hM3Dq-mCherry into the DG. E, 
Confocal images of immunostained DG sections showing co-localization of GABA (white) 
in hM3D expressing (red) CCK interneurons. Arrows highlight colocalized cells in the hilus. 
Scale bar 50 µm.  F, Quantification of GABA expression in hM3D expressing CCK 
interneurons. Bars indicate mean colocalization ± SD for n = 3 sections. G, Whole-cell 
current-clamp recording in acute slice preparation of an initially silent hM3Dq+ CCK 
interneurons upon application of 10 µM CNO.  H, Another sample CCK interneuron with 
basal activity showing increased spiking upon chemogenetic activation with CNO. I, 
Quantification of the fold increase in spike number during 3 to 6 minute episodes of 
chemogenetic activation. Bars indicate means ± SEM.  J, Bilateral injection scheme for 
chemogenetic activation of CCK interneurons and rNSC patch recording in adult CCK-
Cre::Nestin-GFP mice (top), and resulting mCherry expression in CCK interneurons near 
GFP+ adult neural stem cells  (bottom). K, Depolarization of an rNSC by chemogenetic 
activation of CCK interneurons. L, Maintained hyperpolarized Vm of rNSC when CCK 
interneurons were activated in the presence of 2 µM CCK2R antagonist YM022.  M, 
Maintained hyperpolarized Vm of rNSC when CCK interneurons were activated in the 
presence of 5 µM Gαq/11 antagonist YM254890.  N, Quantification of rNSC membrane 
potentials before and during CNO application in ACSF conditions (grey), YM022 blockade 
(red), or YM254890 (blue). Bars indicate mean Vm ± SEM. n = (7, 6, 4) cells from (5, 5, 3) 
animals. O, Magnitude of depolarization due to CNO application. Bars indicate mean ± SEM 
for rNSCs that responded by at least 10 mV from baseline (circles). Triangles = non 





Figure 2-2: CCK interneuron activity induced rNSC depolarization is mediated by a 
glutamatergic relay. 
A, No detected depolarization in a whole-cell patched rNSC to bath of CCK8ns peptide in 
the presence of TTX, blockers for GABAAR (bicuculline), iGluRs (APV, NBQX) and group 
I mGluRs (AIDA). B, Bath application of CCK8ns peptide induced depolarization in a 
whole-cell patched rNSC. C, CCK8ns peptide induced depolarization was blocked by 
CCK2R antagonist YM022.  D, Comparison of the magnitude of depolarization upon bath 
application of CCK8ns peptide in ACSF, Glu/GABA blockade, or CCK2R blockade. Bars 
indicate mean ± SEM for rNSCs that responded by at least 10 mV from baseline (circles). n = 
(5, 3, 3) cells in (4, 2, 3) animals. ANBAT = APV, NBQX, bicuculline, AIDA, TTX. E, 
Percent of rNSCs that responded to CCK8ns application in control and indicated antagonists. 
F, Robust depolarization of rNSC by chemogenetic activation of CCK interneurons (see 
Figure. 1I) during GABAAR blockade (bicuculline). G, Depolarization induced by CCK 
chemogenetic stimulation was prevented by pharmacological blockade of GABAARs, 
iGluRs and mGluRs.  H, Partial depolarization persisted when only GABAARs and iGluRs 
were blocked or when only GABAAR and mGluRs were blocked. I, Magnitudes of  
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(Figure 2-2 continued)  
depolarization during CNO application under indicated conditions of 
GABAergic/Glutamatergic blockade. Bars indicate mean ± SEM for rNSCs that responded 
by at least 10 mV from baseline. p = (0.6 ,0.03, 0.07, 0.05) for all cells (n = 7, 11, 5, 7, 5 cells 
from 5, 10, 4, 6, 4 animals). Students T-test. J, Percent of rNSCs that depolarized by at least 
10 mV from baseline membrane potential after chemogenetic activation of CCK 
interneurons. K, Delay time from CNO application to initiation of depolarizing event for 
responding cells under indicated conditions. p = 0.14 for ACSF vs bicuculline ,0.36 for 
ACSF vs bicuculline/APV/NBQX, 0.25 for ACSF vs BA. Bars indicate mean ± SD. See also 





Figure 2-3: CCK interneuron stimulation reduces local dentate glutamatergic circuitry 
neurons.   
A, Bilateral injection scheme for chemogenetic activation of CCK interneurons and calcium 
imaging in granule cells and mossy cells. B, Overlay of DIC and fluorescence images from 
acute slice preparation exhibiting targeted expression of viral transgenes indicated in A. 
Scale bar 50 µm. C, Sample somatic calcium transients in GCs before and during  
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(Figure 2-3 continued) 
chemogenetic activation of CCK interneurons. D, Quantification of the frequency of GC 
calcium events detected during baseline and then during the chemogenetic activation of CCK 
cells in ACSF for n = 83 cells in 4 animals. p = 0.05 by Paired Student’s T-Test. E, Sample 
somatic calcium transients in MCs before and during chemogenetic activation of CCK 
interneurons. F, Quantification of the frequency of MC calcium events detected during 
baseline and then during the chemogenetic activation of CCK cells in ACSF for n = 56 cells 
in 5 animals. p = 7*10-7 by paired Student’s T-Test. G, Quantification of GC calcium 
transients as in D, but under GABAAR blockade by bicuculline from n = 58 cells from 3 
animals. p = 0.0009. H, Quantification of MC calcium transients as in F, but under 
GABAAR blockade by bicuculline from n = 87 cells from 3 animals. p = 0.1. I, 
Quantification of GC calcium transients as in D, but under CCK2R blockade by YM022 
from n = 49 cells from 2 animals. p = 0.4. J, Quantification of MC calcium transients as in F, 
but under CCK2R blockade by YM022 from n = 52 cells from 3 animals. p = 0.5. K, 
Bilateral injection scheme for chemogenetic activation of CCK cells and YFP labeling of PV 
interneurons. L, Confocal image of stained tissue showing specificity of YFP recombination 
in PV+ interneurons for guided electrophysiology, and mCherry expression in hM3Dq 
targeted hilar CCK cells. M, Sample cell-attached electrophysiological recordings from 
parvalbumin interneurons showing increased spiking in ACSF conditions (top trace), or 
unchanged in YM022 conditions (bottom trace). N, Quantification of fold-changes in spike 
rate relative to baseline for n=(7, 5) cells from (5,3) animals. p = 0.03. O, Bilateral injection 
scheme for chemogenetic activation of CCK cells during whole-cell electrophysiology 
recordings from GCs. P, Overlay of DIC and fluorescence image from acute slice preparation 
exhibiting targeted expression of hM3D-mCherry in the hilus and a patch pipette for 
recording GCs in the GCL. Q, Sample inward IPSCs from visually identified GCs at baseline 
(top, ACSF) or during chemogenetic activation of CCK cells (bottom, CNO) using high 
chloride internal solution. R, Time-course of IPSC frequencies (binned every 30 s) from a 
GC showing CNO induced increase in inhibitory events, abolished by GABAergic receptor 
antagonists. S, Quantification of mean IPSC frequencies for n = 5 GCs at baseline and during 
chemogenetic CCK activation. T, Computed fold change in GC IPSC frequency for cells in 




Figure 2-4: CCK interneuron activity induced rNSC depolarization requires dentate 
astrocytic intermediates.  
A, Bilateral injection scheme for chemogenetic activation of CCK interneurons and rNSC 
patch recording in adult CCK-Cre::Nestin-GFP mice during astrocyte blockade. B, Abolition  
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(Figure 2-4 continued) 
of CCK induced rNSC depolarization when incubated in Fluorocitric acid (FC) (top trace). 
FC does not alter the ability or rNSCs to respond to glutamate (bottom trace). C, 
Quantification of rNSC membrane potentials before and during CNO application in ACSF 
conditions (grey) or FC (blue). Bars indicate mean Vm ± SEM. n = (7, 3) cells from (5, 2) 
animals. D, Magnitude of depolarization due to CNO application. Bars indicate mean ± SEM 
for rNSCs that responded by at least 10 mV from baseline (circles). Triangles = non 
responding rNSCs.  E, Bilateral injection scheme for chemogenetic activation of CCK 
interneurons and calcium imaging of hippocampal astrocytes. F, Confocal scan of animal 
described in E, showing associations of mCherry+ CCK interneurons apposed to GFAP+ 
astrocytic processes. Scale bars 100 µm, 20 µm. G, Sample calcium transients in astrocytes 
before and during chemogenetic activation of CCK interneurons. H, Quantification of the 
frequency of astrocyte calcium events detected during baseline and then during the 
chemogenetic activation of CCK cells. n = 118 from 1 animal. p = (0.0001) by paired 
Student’s T-test.  I, Sample calcium transients in astrocytes before and during chemogenetic 
activation of CCK interneurons under CCK2R blockade by YM022. J, Quantification of the 
frequency of astrocyte calcium events detected during baseline and then during the 
chemogenetic activation of CCK cells in YM022. n = 127 from 1 animals. p = (0.013) by 
paired Student’s T-test.  K, Quantification of the frequency of astrocyte calcium events 
detected during baseline and then during the chemogenetic activation of CCK cells while 
under GABAergic blockade. n = 80 from 1 animal. p = (0.002) by paired Student’s T-test.  L, 
Quantification of the frequency of astrocyte calcium events detected during baseline and then 
during application of CCK peptide while under action potential blockade by TTX. n = 46 
from 1 animal. p = (0.003) by paired Student’s T-test.  M, Confocal scan of GFAP staining 
from DIO-mCherry or chemogenetically activated DIO-hM3Dq-mCherry animals showing 
no signs of reactive astrogliosis. N, Quantification GFAP stainings described in M for 
n=(2,3) animals, p = (0.45). O, Bilateral injection scheme for chemogenetic activation of 
CCK interneurons and BAPTA filling of astrocytes for electrophysiological recordings from 
rNSCs in CCK-Cre::Nestin-GFP mice. P, Overlay of DIC and fluorescence images from 
acute slice preparation exhibiting targeted expression of viral transgenes indicated in A. Top 
image shows BAPTA filling pipette on an mCherry+ astrocyte in the hilus. Lower image 
shows recording configuration from GFP+ rNSC. Scale bar 50 µm. Q, Sample trace from 
GFP+ rNSCs following 20 minutes astrocyte perfusion with high BAPTA internal solution 
showing no depolarization via CCK activation. R, rNSCs still depolarize to glutamate 
application after astrocyte BAPTA fill. S, Quantification of the depolarization magnitude of 
rNSCs when CCKs were chemogenetically activated following astrocyte BAPTA fill. See 




Figure 2-5: CCK interneuron stimulation promotes activation of rNSCs through Gq 
signaling and downstream MAPK/ERK pathway.   
A, Experimental paradigm for quantification of phospho-ERK signaling in adult neural stem 
cells in response to acute, chemogenetic activation of CCK interneurons. B, Representative 
image of a phospho-ERK+ Nestin+ adult neural stem cell in the DG. Scale bar: 10 µm. The 
yellow arrows highlight the soma of a phospho-ERK+ adult rNSC. C, Activation of CCK 
interneurons increased the density of phospho-ERK+ rNSCs in the DG. Dots represent a 
normalized quantification per animal (n = 4 and 5 animals). Bars indicate means ± SD; p = 
0.013; Students T-test.  D, Experimental paradigm for quantification of phospho-RB in 
rNSCs in response to acute, chemogenetic activation of CCK interneurons.  E,  
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(Figure 2-5 continued) 
Representative image of a phospho-RB+ Nestin+ rNSC in the DG. Scale bar 10 µm.  The 
yellow arrows highlight the soma of a phospho-RB+ rNSC.  F, Activation of CCK 
interneurons increased the density of phospho-RB+ rNSCs in the DG. Dots represent a 
normalized quantification per animal (n = 5 and 4 animals). Bars indicate means ± SD; p = 
0.008 Students T-test. G, Bilateral injection scheme and H, experimental paradigm for 
quantification of rNSC proliferation in response to 4 days of in vivo chemogenetic activation 
of CCK interneurons.  I, Representative image of a Nestin+ EdU+ adult neural stem cell in 
the DG. Scale bar 10 µm. Yellow arrow highlights the EdU+ soma of an adult rNSC.  J-M, 
Activation of CCK interneurons increased both the proportion (J) and density (K) of 
proliferating adult neural stem cells in the DG while also increasing the density of all 
proliferating cells in the DG (M).  No change in the density of rNSCs in the DG was 
observed (L). Dots represent a normalized quantification per animal (n = 5 and 6 animals). 
Bars indicate means ± SD; p = (0.03, 0.05, 0.80, 0.003) Students T-test.  N, Experimental 
paradigm for quantification of rNSC proliferation in response to 3 weeks of in vivo 
chemogenetic activation of CCK interneurons. O, Representative image of a DCX+ adult-
born immature neuron in the DG. Scale bar 50 µm. P, Density of DCX staining after longer-
term chemogenetic activation of CCK interneurons. Q, No change in the density of rNSCs in 




Figure 2-6: Suppression of CCK Synthesis decreases rNSC activation and proliferation 
of newborn progeny.  
A, Bilateral injection scheme for inhibition of CCK synthesis through injection of AAV5-
CMV-shCCK-eGFP into the DG of adult BL6 mice.  B, Experimental paradigm for 
quantification of rNSC proliferation in response to 1 month of inhibition of CCK synthesis.   
C, Western blot and D densitometry analysis of bands demonstrate suppression of CCK 
synthesis in the DG after injection of AAV5-CMV-shCCK-eGFP.  p = 0.02 from n = (3, 3) 
animals; Students T-test. E, Expression of GFP in infected cells in the hilus of DG from 
AAV5-shScramble or AAV5-shCCK injected animals showing reduction of CCK levels 
(red) as detected by proCCK antibody. Arrow heads indicate cells positive for CCK. Scale 
bars 100 µm , 20 µm . F-I, Suppression of CCK synthesis results in a decrease in the 
proportion (F) and density (G) of proliferating adult neural stem cells in the DG as well a 
decrease in the density of total proliferating cells in the DG (H).  No change in the density of  
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(Figure 2-6 continued) 
adult neural stem cells in the DG was observed (I). Dots represent a normalized 
quantification per animal (n = 3 and 4 animals). Bars indicate means ± SD; p = (0.011, 0.04, 




Figure 2-7: Knockdown of CCK induces changes in genes related to immune reactivity 
and reduced proliferation reflecting pathology of AD.   
A, Confocal scans from shScramble and shCCK injected animals showing dramatic increase 
in GFAP staining when CCK levels are reduced. Scale bar 100 µm. B, Quantification of %  
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(Figure 2-7 continued) 
GFAP volume for n= (4,4) animals. p = 0.03. C, Volcano plot of fold changes in gene 
expression highlighting differentially expressed genes in shCCk vs shScramble injected 
animals. D, Heatmap of 18 DEGs related to reactive astrocyte states in three animals from each 
treatment group. Genes are organized into general reactive astrocyte genes (Pan), as well as by 
genes related to type A1 and A2 reactive astrocytes. Color indicates direction and relative 
magnitude of FPKMs. E, Gene Ontology terms identified from analysis of all 452 DEGs 
highlighting immune processes and negative regulation of proliferation. F, Heatmap of 21 
DEGs related to negative control of proliferation for three animals in each treatment group. 
Color indicates direction and relative magnitude of FPKMs. G, Expression of the 21 DEGs 
associated with negative cell proliferation in rNSCs (Shin et al). H, Confocal scans from 8 
month old WT and 5xFAD animals showing dramatic increase in GFAP staining in the AD 
model animal. Scale bar 100 µm. I, Quantification of % GFAP volume for n= (5,3) animals. p 
= 0.03. J, Western blot of CCK protein levels in hippocampal lysates from 5xFAD vs WT 
animals. K, Densitometry analysis of blots in J, revealing decreased CCK peptide levels in AD 
animals. L-N, Quantification of proliferation in 5xFAD animals showing reduced density (L) 
and proportion (M) of proliferating stem cells, as well as reduced density of total proliferating 
cells (N) in the SGZ of AD animals. p = (0.003,0.002,0.006) for n = (5,3) animals. See also 




Figure 2-8: AAV2 viral expression of excitatory DREADD in CCK cells of the dentate 
gyrus.   
A, AAV2-hSyn-DIO-hM3Dq-mCherry expression is restricted to the hilus of the DG from 
dorsal to ventral hippocampal sections. Scale bar 500 µm. B, Confirmation of DREADD 
activation of CCK interneurons by calcium imaging. (Left) AAVDJ-EF1α-DIO-GCaMP6s 
was co-injected with hM3Dq virus to both activate and image.  (Right) Sample calcium 
imaging sequence and ∆F/F quantification of a hilar hM3Dq+ GCaMP6+ CCK interneuron 




Figure 2-9: Ionotropic and metabotropic glutamate agonists induce depolarization of 
rNSC membrane potentials.   
Bath application of AMPA (A), NMDA (B) or DHPG (C) onto acute slice induced transient 
(A, B) or sustained (C) depolarization of rNSCs. D, Quantification of the depolarization 
magnitude of rNSCs upon bath application of AMPA, NMDA, or DHPG. Symbols indicate 
responding (≥ 10 mV depolarization) rNSCs. p = 0.09 for AMPA vs DHPG and p = 0.12 for 
NMDA vs DHPG in n = (5, 6, 3) cells from  3 animals. Bars indicate mean ± SEM in the 





Figure 2-10: Activation of CCK interneurons reduces the frequency of calcium 
transients in principle glutamatergic neurons of the DG via CCK2R dependent 
GABAergic signaling.   
A, Sample somatic calcium transients in GCs before and during chemogenetic activation of 
CCK interneurons recorded in the presence of GABAAR blocker bicuculline. B, Sample  
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(Figure 2-10 continued) 
somatic calcium transients in GCs before and during chemogenetic activation of CCK 
interneurons recorded in the presence of CCK2R antagonist YM022. C, Quantification of the 
fold change in the frequency of calcium events before and during CNO application exhibiting 
a CCK2R dependent GABAergic inhibition of GCs for n = (83,58,49) cells from (4,3,2) 
animals. p = (8.7*10-5, 0.11). Some underlying CCK driven excitation is revealed in 
bicuculline conditions. D, Quantification of the area under the calcium trace for granule cells, 
reflecting cumulative amplitude and duration of calcium events in ACSF and CNO 
conditions. n = 83 cells from 4 animals, p = 0.54.  E, Sample somatic calcium transients in 
MCs before and during chemogenetic activation of CCK interneurons recorded in the 
presence of GABAAR blocker bicuculline. F, Sample somatic calcium transients in MCs 
before and during chemogenetic activation of CCK interneurons recorded in the presence of 
CCK2R antagonist YM022. G, Quantification of the fold change in the frequency of calcium 
events before and during CNO application exhibiting a CCK2R dependent GABAergic 
inhibition of MCs for n = (56,87,52) cells from (5,3,5) animals. p = (1.4*10-3, 0.02). H, 
Quantification of the area under the calcium trace for mossy cells, reflecting cumulative 
amplitude and duration of calcium events in ACSF and CNO conditions. n = 56 cells from 5 




Figure 2-11: Labeling, calcium inactivation, or direct Gq stimulation of hippocampal 
astrocytes.   
A, Bilateral injection scheme for chemogenetic activation of CCK neurons by AAV2-DIO-
hM3Dq-mCherry and astrocyte targeting for patch pipette perfusion by AAV8-GFAP-
mCherry. B, Confocal confirmation of simultaneous viral trans-gene expression in astrocytes 
and CCK neurons. Red fluorescence in astrocytes was intense and colocalized with GFAP 
antibody (yellow arrowheads, expanded in (b) panels), while expression of hM3Dq-mCherry 
was weak and colocalized with CCK antibody (blue arrowheads, expanded in (c) panels). 
High and low 568 nm laser intensity was used to gather representative images. Scale bar 100 
µm. C, Bilateral injection scheme for confirmation of BAPTA attenuation of astrocyte 
network by co-injection of AAV2/5-GFAPGCaMP6-LCK for calcium imaging of astrocytes 
and AAV8-GFAP-mCherry for visual guidance of patch pipettes. D, Overlay of DIC and 
fluorescence images from acute slice preparation exhibiting targeted expression of viral 
transgenes indicated in A. Scale bar 50 µm. E, Sample calcium transients in nearby DG 
astrocytes before and 20 minutes after whole-cell perfusion of a single hilar astrocyte with 
high BAPTA internal solution. F, Quantification of the frequency of astrocyte calcium events  
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(Figure 2-11 continued) 
detected during baseline and then after BAPTA perfusion. Only 1 event was detected after 
perfusion, for n=22 cells. G, Bilateral injection scheme for direct Gαq stimulation of 
astrocytes by AAV2/5-GFAP-hM3Dq-mCherry mediat3d gene expression of excitatory 
DREADDs and electrophysiological recordings of rNSCs in Nestin-GFP animals. H, Overlay 
of DIC and fluorescence images from acute slice preparation exhibiting targeted expression 
of viral transgenes indicated in G. Scale bar 50 µm. I, Depolarization of a rNSC by 
chemogenetic activation of astrocytes. J, Quantification of membrane depolarizations due to 




Figure 2-12: Transcriptome analysis for hippocampus samples subjected to knockdown 
of CCK in the DG.   
A, Principle component analysis of three shCCK and three shScramble treated animals. 
Component 1 and Component 2 account for 37% and 22% of the respective sample variance. 
B, Heat map of DEGs in the Immune System Gene Ontology term (largest category).  C, PPI 
STRING network on negative proliferation DEGs showing putative gene relationships 




gene locus shScrambled_FPKM shCCK_FPKM log2(fold_change) p_value q_value significant 
Btg2 chr1:135971441-135975732 11.9573 17.3083 0.533569 5.00E-05 0.0027002 yes 
Cd37 chr7:52489001-52494485 2.90672 5.409 0.895971 5.00E-05 0.0027002 yes 
Cd9 chr6:125410283-125444773 39.7483 61.632 0.632788 5.00E-05 0.0027002 yes 
Kat2b chr17:53706295-53812046 3.54081 4.94879 0.482996 0.00015 0.0071724 yes 
Lyn chr4:3605267-3718759 3.54153 5.62739 0.668093 5.00E-05 0.0027002 yes 
Ndrg1 chr15:66760879-66801203 16.6475 22.5899 0.440379 5.00E-05 0.0027002 yes 
Smad1 chr8:81862297-81923367 9.58469 6.83465 -0.487864 5.00E-05 0.0027002 yes 
Csf1r chr18:61265225-61290793 33.2378 42.0041 0.337705 0.00085 0.0289021 yes 
Cbfa2t3 chr8:125149035-125223009 7.98652 5.45916 -0.54889 5.00E-05 0.0027002 yes 
Cdkn1a chr17:29227930-29237667 5.37178 8.16964 0.604872 5.00E-05 0.0027002 yes 
Eif2ak2 chr17:79251889-79281912 1.63083 3.35376 1.04017 5.00E-05 0.0027002 yes 
Inpp5d chr1:89516886-89617083 2.90726 4.45541 0.615895 5.00E-05 0.0027002 yes 
Ifitm3 chr7:148195488-148196643 17.4443 60.1321 1.78538 5.00E-05 0.0027002 yes 
Irf1 chr11:53583515-53591876 5.71556 8.51168 0.57455 5.00E-05 0.0027002 yes 
Ifit3 chr19:34658018-34663472 3.43844 21.2825 2.62984 5.00E-05 0.0027002 yes 
Lefty1 chr1:182865169-182868532 0.459194 1.1279 1.29647 0.0018 0.0499754 yes 
Pth1r chr9:110624588-110649649 1.38083 2.45097 0.827813 0.00035 0.0145615 yes 
Slfn2 chr11:82878613-82884180 0.812992 2.98921 1.87845 5.00E-05 0.0027002 yes 
Tlr2 chr3:83640193-83645530 0.552152 2.07782 1.91194 5.00E-05 0.0027002 yes 
Tob2 chr15:81678699-81688756 9.00533 6.8636 -0.391814 0.0012 0.0374721 yes 
Tgfbr2 chr9:115996812-116084481 4.85859 6.35977 0.388436 0.00155 0.0448425 yes 
  








gene locus shScrambled_FPKM shCCK_FPKM log2(fold_change) p_value q_value significant 
PAN reactive 
S1pr3 chr13:51503986-51518166 2.34366 3.9946 0.769291 5.00E-05 0.0027 yes 
Cxcl10 chr5:92760866-92843653 0.373397 11.8056 4.98262 5.00E-05 0.0027 yes 
Cd44 chr2:102651299-102741822 1.84914 3.46093 0.9043 5.00E-05 0.0027 yes 
Osmr chr15:6763576-6824313 2.08554 3.11661 0.579559 0.0001 0.005026 yes 
Serpina3n chr12:105644917-105652539 36.4881 54.5983 0.581431 5.00E-05 0.0027 yes 
Aspg chr12:113344893-113365784 1.31188 2.31136 0.817102 5.00E-05 0.0027 yes 
Gfap chr11:102748649-102758514 207.623 457.224 1.13893 5.00E-05 0.0027 yes 
Vim chr2:13495937-13504453 27.9102 62.7853 1.16964 5.00E-05 0.0027 yes 
A1-specific 
C3 chr17:57343395-57367559 0.219086 3.58967 4.03428 5.00E-05 0.0027 yes 
H2-T23 chr17:36131448-36175119 6.0047 22.0675 1.87776 5.00E-05 0.0027 yes 
H2-D1 chr17:35400038-35462354 25.6709 91.2499 1.82969 5.00E-05 0.0027 yes 
Ggta1 chr2:35255698-35316945 1.57135 2.69307 0.777249 5.00E-05 0.0027 yes 
Iigp1 chr18:60535682-60552283 1.18891 5.36266 2.17331 5.00E-05 0.0027 yes 
Gbp2 chr3:142283626-142300972 1.62003 10.9551 2.75752 5.00E-05 0.0027 yes 
Psmb8 chr17:34335139-34338399 3.44531 10.6432 1.62723 5.00E-05 0.0027 yes 
A2-specific 
Ptx3 chr3:65857479-66100759 0.299288 1.06309 1.82865 0.0002 0.00912 yes 
S100a10 chr3:93359038-93368567 21.7831 30.5188 0.48649 0.0015 0.043857 yes 
 










CHAPTER 3 DISCUSSION AND CONCLUSIONS 
 
CCK regulates rNSC activity through inducing glutamate release from local astrocytes 
This study identifies dentate CCK interneurons as a critical component of the 
neurogenic niche that utilize endogenous CCK to regulate rNSC activity via local astrocytes.  
CCK dependent astrocytic release of glutamate then drives rNSC activation through activation 
of both mGluR and iGluR receptors on rNSCs.  Phopsho-ERK is a well known downstream 
effector of both mGluR and iGluR receptors and this study also found that phopsho-ERK was 
upregulated in rNSCs in response to CCK interneuron activation.  Furthermore, 
hyperphosphorylation of RB is also observed in rNSCs in response to rNSC activity.  Our data 
demonstrated that both mGluR and iGluR activation is required for maximum depolarization 
of rNSCs and that activation of just a single type of glutamate receptor is insufficient to induce 
full rNSC activation  (Figure 2-2: J).  As mGluRs are Gαq coupled GPCRs and iGluRs are 
ligand ion channels, the method by which they activate phospho-ERK is likely to involve 
different intermediate signaling proteins.  Previous studies demonstrated that iGluRs regulate 
phospho-ERK activity through phosphoinositide 3-kinase (PI3K) and/or Ras-guanine 
nucleotide releasing factors (RasGRFs) while group I mGluRs regulate phopsho-ERK 
signaling through phospholipase Cβ1(PLCβ1) and nositol-1,4,5-triphosphate (IP3)59.  
Interestingly, our lab previously demonstrated that CCK dependent activation of rNSCs is 
partially inhibited with the intracellular addition of a PLCβ1 blocker in rNSCs (data not 
shown).  This would further support that the idea that activated type I mGluRs do in fact signal 




ERK signaling.  Whether activation of iGluRs on rNSCs also induces phospho-ERK signaling 
in rNSCs remains to be determined.  
 
c-Myc as a potential downstream effector of phospho-ERK in rNSCs 
As phospho-ERK is an upstream signaling node that can induce cell proliferation 
through a number of different intermediates, and phospho-RB is one of the most downstream 
effectors of MAPK signaling, the intermediate effectors of phospho-ERK remain 
undiscovered.  There is no study that has identified any of the downstream effectors of either 
glutamate receptors or ERK signaling in rNSCs in the DG.  One well studied downstream 
effector of phospho-ERK that is also linked to cell cycle regulation is c-Myc69.  Two studies 
using cultured embryonic neural stem cells derived from the lateral ventricles demonstrated 
that c-Myc is required for normal proliferation  of neural stem cells and that overexpression of 
c-myc increases neural stem cell prolifeation70,71.  While there is no evidence of c-myc being 
required for rNSC proliferation in the DG, these studies make it is an interesting, putative 
downstream effector of phospho-ERK in rNSCs and an excellent candidate for further study.  
The same method from this paper used to quantify the density of phospho-ERK+ rNSCs in 
response to CCK interneuron activation could also be used quantify activation of c-myc in 
response to CCK interneuron activation.  Previous studies have demonstrated that once 
phospho-ERK is activated, it then phosphorylates serine 62 on the n-terminal of c-myc.  Many 
commercial antibodies for this phosphorylation site are readily available72,73.  Therefore, by 
quantifying the increase in phosphorylation at serine 62 of c-myc in response to CCK 
interneuron activation it could be determined whether or not c-myc is in fact a downstream 




Identifying novel molecular mechanisms that mediate CCK interneuron dependent 
activation of rNSCs 
To date, very few studies have addressed the molecular mechanisms by which rNSCs 
respond to external stimuli.  Previous attempts at this have mostly used cultured adult neural 
stem cells.  However, this is a highly artificial system compared to rNSCs in vivo.  For 
example, nearly all adult neural stem cells in a culture are constantly proliferating whereas 
almost all rNSCs in vivo (~95%) are quiescent until they are activated to begin proliferation74.  
Furthermore, cultured adult neural stem cells do not express certain markers of rNSCs in vivo, 
such as GFAP.  Therefore, these cells in these cultures likely represent an artificial cell type 
that has similarities between an rNSC and a progenitor.  This is why we chose not to use the 
cultured adult neural stem cells to try and identify the molecular mechanisms that are involved 
in mGluR and iGluR mediated activation of rNSCs.  However, using in vivo methods to 
identify novel molecular mechanisms is very difficult and so we were only able to focus on 
molecular pathways that were previously demonstrated to regulate neural stem cell activity.  
While this study demonstrated that the MAPK pathway is a strong activator of rNSCs in 
response to activation of glutamate receptors, harnessing neurogenesis in the treatment of 
disease would require identifying more selective drug targets than ERK signaling because 1) 
ERK1/2 is highly expressed in a number of neurons in the DG and so administration of either 
a small molecule inhibitor or activator of the MAPK pathway would not be selective to rNSCs 
2) ERK1/2 is an upstream signaling node and so likely plays a critical role in many rNSC 
functions.  To identify molecular mechanisms that mediate CCK interneuron activation of 
rNSCs, it is necessary to use a high throughput method of transcriptional analysis such as 




in the DG. However, these groups did not attempt to compare transcriptional profiles of rNSCs 
between experimental groups and so it is not known how rNSC transcriptional profiles would 
change in response to external stimuli 18,75.  I do believe that the methods used in Berg et al 
would be an excellent way to study the transcriptomes of rNSCs in response to activation of 
CCK interneurons.  Comparing the transcriptomes of rNSCs from mice that underwent CCK 
interneuron activation with control mice would likely identify novel molecular mechanisms 
that mediate rNSC activation in response to glutamate.  Once candidate genes and pathways 
had been identified, they would then need to be studied in loss-of-function or gain-of-function 
experiments in vivo to demonstrate their bona fide role in CCK interneuron mediated rNSC 
activation.  This would require a method to selectively overexpress or knockout a particular 
gene of interest.  Previous groups have done this with the use of transgenic mouse lines with 
Nestin driven expression of inducible Cre recombinase.  However these lines are notoriously 
leaky and are not selective between rNSCs and progenitors76.  Fortunately, our lab published 
a paper demonstrating the selectivity of AAV4 for rNSCs in vivo77.  This paper, and recent 
data from our lab, demonstrated that AAV4 can be used to either overexpress a particular gene 
of interest in rNSCs or can also be used in combination with a floxed mouse line for selective 
knockout of a particular gene in rNSCs.  Therefore, AAV4 could then be used in both loss of 
function and gain of function experiments to determine if candidate genes from the RNAseq 
experiment are actually required for CCK interneuron mediated rNSC activation.  
 
CCK induces an inhibitory tone to prevent depletion of the rNSC pool 
One important question we wanted address in this study is how CCK induces rNSC 




depleting the rNSC pool.  This study determined that CCK release exerts an inhibitory tone to 
the DG by inhibiting excitatory interneurons through activation of local PV+ interneurons.  
PV+ interneurons inhibit excitatory neurons of the DG through release of GABA.  The 
inhibitory tone in the neurogenic niche is critical for maintaining the NSC pool, as evidenced 
by recent studies from us and others demonstrating that network hyperexcitability induces a 
transient increase in neurogenesis followed by rNSC pool depletion78,79.   One limitation of 
this study is that we did not determine whether CCK mediated activation of astrocytes also 
exerts an effect on PV interneurons.  If astrocytes do in fact exert an effect on PV+ 
interneurons, this would be yet another example of how astrocytes regulate DG homeostasis 
by preventing hyperexcitability of local excitatory neurons through activation of PV+ 
interneurons. 
 
The potential effect of CCK on intermediate progenitors 
This study demonstrated the CCK dependent activation of astrocytes drives rNSC 
proliferation and increased production of immature neurons.  However, we did not investigate 
whether either CCK or astrocytic glutamate directly affect later stages of neurogenesis 
including intermediate progenitors and immature neurons.  One interesting finding from our 
study is that not only did CCK interneuron activation increase the density of proliferating 
rNSCs in the DG, it also increased the total density of proliferating cells in the DG.  As the 
EdU quantification only included cells that were in the SGZ, it is highly unlikely this would 
include proliferating reactive astrocytes.  Without co-staining with a marker of intermediate 
progenitors, such as TBR2, it is difficult to be certain of the identity of these cells that show 




would be the most likely possibility given they are the only other significantly proliferative 
cell type in the SGZ besides rNSCs.  While Shin et al did not detect the presence of CCK 
receptors on intermediate progenitors, and so it is unlikely that CCK would be driving 
proliferation of intermediate progenitors, both types of type I mGluRs were detected on these 
cells.  Therefore, the most plausible hypotheses for how astrocytic glutamate might induce 
progenitor proliferation would be that 1) increased rNSCs proliferation results in increased 
production of intermediate progenitors 2) existing intermediate progenitors respond to 
glutamate by increasing their proliferation or 3) astrocyte activation results in release of other 
pro-proliferative factors, besides glutamate, that drive proliferation of intermediate 
progenitors. 
 
CCK as a regulator of homeostasis in the neurogenic niche 
This study identified CCK as a master regulator of the neurogenic niche.  CCK 
dependent activation of astrocytes induced increased rNSC proliferation and neurogenesis 
while also exerting an inhibitory tone to DG excitatory neurons.  Inhibiting CCK synthesis 
resulted in a disease like state in which astrocyte reactivity was highly increased and rNSC 
proliferation was significantly decreased.  This would suggest that astrocytes are able to 
“sense” the current CCK levels in the DG and react accordingly.  It remains to be determined 
the relevant context in which DG CCK levels might be increased or decreased in response to 
a particular external stimuli or disease state.  DG interneurons have connections with many 
regions of the brain and so, through their regulation of rNSCs, allow for external stimuli to 
influence neurogenesis.  CCK interneurons are highly susceptible to neuromodulation and thus 




regulation through altered CCK activity80–82.  Several recent studies have shown that 
neuromodulatory cholinergic inputs can act on CCK neurons to impact their activity and 
network dynamics83,84. Furthermore, a recent study applied microarray analysis of human 
hippocampal tissues and showed that physical exercise significantly increased hippocampal 
CCK expression, while AD significantly reduced its expression85.  It is more complicated to 
determine the exact reason why low CCK levels would drive astrocyte reactivity and decreased 
neurogenesis as this is more likely to occur in a disease state, such as AD.  Our data 
demonstrated that 5xFAD mice have decreased CCK levels as compared to wild type mice.  
Does this represent a beneficial response to disease and a mechanism by which the brain can 
mediate the detrimental effects of the disease or is this simply an effect that is caused by the 
disease that further exacerbates the already occurring cognitive defects.  The role of 
neuroinflammation in AD and whether it is beneficial or detrimental remains highly 
contentious86, however, the anti-inflammatory role of CCK has been implicated in the 
peripheral system but has never been reported in the central nervous system87–89.  Therefore, 
taken together with the hypothesis that neuroinflammation does actually serve a beneficial role 
in a neurodegenerative disease such as AD, it can be concluded that low CCK levels act as an 
“alarm” to DG astrocytes to enter into a reactive state and release trophic factors that can 
alleviate the effects of neurodegenerative disease.  In this scenario, it still remains to be 
determined what the benefit of decreasing rNSC proliferation would be.  Hippocampal 
hyperexcitability has been determined to be an early event in AD and likely contributes to 
impairment in memory loss90.  Therefore, as network hyperexcitability would likely lead to 
depletion of the rNSC pool from excessive rNSC proliferation, it is plausible that suppression 




RNA-Seq analysis identified significant changes in a gene network involved in positive 
regulation of ERK signaling (data not shown), implicating the presence of DG 
hyperexcitability in mice in which CCK synthesis was suppressed. This would argue that 
suppression of CCK synthesis results in network hyperexcitability and so rNSC proliferation 
is decreased in response to this in order to prevent depletion of the pool.  Interestingly, several 
studies also showed that interneuron dysfunction contributes to network hyperexcitability in 
mouse models of AD, which was thought to be a contributing factor to astrogliosis91–95.  
However, it still remains to be determined whether reduced CCK expression in 5xFAD mice 
plays a causal role in hippocampal hyperexcitability, and if so, is this a beneficial response to 





Figure 3-1: Model of dentate CCK interneurons regulating key behavior of rNSCs 
through differential astrocyte states.   
Dentate CCK terminals modulate glutamate release from astrocytes in a CCK2R-depedent 
fashion, which in turn activates iGluRs and mGluRs on rNSCs. PV interneurons, meanwhile 
are excited by CCK, and release GABA. Activation of iGluRs and mGluRs on rNSCs induces 
intracellular signaling cascades and leads to phosphorylation of ERK1/2.  Phosphorylated 
ERK1/2 then translocates to the nucleus where it drives further signaling events that result in 
hyperphosphorylation of RB, thus preventing it from binding the transcription factor E2F.  
Unbound E2F can then drive transcription of genes and promote G1-S cell cycle progression. 
Conversely, reduced CCK levels reflect pathogenic states, and result in immune activation, 




(Figure 3-1 continued) 








1. Altman, J. Are New Neurons Formed in the Brains of Adult Mammals? Source: Science, 
New Series vol. 135 (1962). 
2. Toda, T. & Gage, F. H. Review: adult neurogenesis contributes to hippocampal 
plasticity. Cell and Tissue Research vol. 373 693–709 (2018). 
3. Eriksson, P. S. et al. Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313–
1317 (1998). 
4. Spalding, K. L. et al. XDynamics of hippocampal neurogenesis in adult humans. Cell 
153, 1219 (2013). 
5. Kempermann, G. et al. Human Adult Neurogenesis: Evidence and Remaining 
Questions. Cell Stem Cell vol. 23 25–30 (2018). 
6. Boldrini, M. et al. Human Hippocampal Neurogenesis Persists throughout Aging. Cell 
Stem Cell 22, 589-599.e5 (2018). 
7. Moreno-Jiménez, E. P. et al. Adult hippocampal neurogenesis is abundant in 
neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. 
Nature Medicine vol. 25 554–560 (2019). 
8. Ming, G. li & Song, H. Adult Neurogenesis in the Mammalian Brain: Significant 
Answers and Significant Questions. Neuron vol. 70 687–702 (2011). 
9. Ma, D. K., Bonaguidi, M. A., Ming, G. L. & Song, H. Adult neural stem cells in the 
mammalian central nervous system. Cell Research vol. 19 672–682 (2009). 
10. Yau, S. Y., Li, A. & So, K. F. Involvement of Adult Hippocampal Neurogenesis in 
Learning and Forgetting. Neural Plasticity vol. 2015 (2015). 
11. Immordino-Yang, M. H. & Singh, V. Hippocampal contributions to the processing of 
social emotions. Hum. Brain Mapp. 34, 945–955 (2013). 
12. Kim, E. J., Pellman, B. & Kim, J. J. Stress effects on the hippocampus: A critical review. 
Learning and Memory vol. 22 411–416 (2015). 
13. Santarelli, L. et al. Requirement of hippocampal neurogenesis for the behavioral effects 
of antidepressants. Science (80-. ). 301, 805–809 (2003). 
14. Saxe, M. D. et al. Ablation of hippocampal neurogenesis impairs contextual fear 
conditioning and synaptic plasticity in the dentate gyrus. Proc. Natl. Acad. Sci. U. S. A. 
103, 17501–17506 (2006). 
15. Kitabatake, Y., Sailor, K. A., Ming, G. li & Song, H. Adult Neurogenesis and 
Hippocampal Memory Function: New Cells, More Plasticity, New Memories? 
Neurosurgery Clinics of North America vol. 18 105–113 (2007). 




Neurogenesis. PLoS One 3, e1959 (2008). 
17. Snyder, J. S., Soumier, A., Brewer, M., Pickel, J. & Cameron, H. A. Adult hippocampal 
neurogenesis buffers stress responses and depressive behaviour. Nature 476, 458–462 
(2011). 
18. Shin, J. et al. Single-Cell RNA-Seq with Waterfall Reveals Molecular Cascades 
underlying Adult Neurogenesis. Cell Stem Cell 17, 360–372 (2015). 
19. Shen, Q. et al. Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of 
Neural Stem Cells. doi:10.1126/science.1095505. 
20. Palmer, T. D., Willhoite, A. R. & Gage, F. H. Vascular niche for adult hippocampal 
neurogenesis. J. Comp. Neurol. 425, 479–494 (2000). 
21. Bonaguidi, M. A. et al. Noggin expands neural stem cells in the adult hippocampus. J. 
Neurosci. 28, 9194–9204 (2008). 
22. Mira, H. et al. Signaling through BMPR-IA regulates quiescence and long-term activity 
of neural stem cells in the adult hippocampus. Cell Stem Cell 7, 78–89 (2010). 
23. Yousef, H. et al. Age-Associated Increase in BMP Signaling Inhibits Hippocampal 
Neurogenesis. Stem Cells 33, 1577–1588 (2015). 
24. Song, J. et al. Neuronal circuitry mechanism regulating adult quiescent neural stem-cell 
fate decision. Nature 489, 150–154 (2012). 
25. Song, J. et al. Parvalbumin interneurons mediate neuronal circuitry-neurogenesis 
coupling in the adult hippocampus. Nat. Neurosci. 16, 1728–1730 (2013). 
26. Nochi, R. et al. Involvement of metabotropic glutamate receptor 5 signaling in activity-
related proliferation of adult hippocampal neural stem cells. Eur. J. Neurosci. 36, 2273–
2283 (2012). 
27. Dindler, A., Blaabjerg, M., Kamand, M., Bogetofte, H. & Meyer, M. Activation of 
Group II Metabotropic Glutamate Receptors Increases Proliferation but does not 
Influence Neuronal Differentiation of a Human Neural Stem Cell Line. Basic Clin. 
Pharmacol. Toxicol. 122, 367–372 (2018). 
28. Kepecs, A. & Fishell, G. Interneuron cell types are fit to function. Nature vol. 505 318–
326 (2014). 
29. Defelipe, J. et al. New insights into the classification and nomenclature of cortical 
GABAergic interneurons. Nat. Rev. Neurosci. 14, 202–216 (2013). 
30. Beinfeld, M. C., Meyer, D. K., Eskay, R. L., Jensen, R. T. & Brownstein, M. J. The 
distribution of cholecystokinin immunoreactivity in the central nervous system of the 
rat as determined by radioimmunoassay. Brain Res. 212, 51–57 (1981). 
31. Kritzer, M. F., Innis, R. B. & Goldman‐Rakic, P. S. Regional distribution of 
cholecystokinin receptors in primate cerebral cortex determined by in vitro receptor 




32. Köhler, C. & Chan-Palay, V. Cholecystokinin-octapeptide (CCK-8) receptors in the 
hippocampal region: a comparative in vitro autoradiographic study in the rat, monkey 
and the postmortem human brain. Neurosci. Lett. 90, 51–56 (1988). 
33. Wang, T. C. et al. Pancreatic gastrin stimulates islet differentiation of transforming 
growth factor α-induced ductular precursor cells. J. Clin. Invest. 92, 1349–1356 (1993). 
34. Rooman, I., Lardon, J. & Bouwens, L. Gastrin stimulates β-cell neogenesis and 
increases islet mass from transdifferentiated but not from normal exocrine pancreas 
tissue. Diabetes 51, 686–690 (2002). 
35. Yeh, C. Y. et al. Mossy Cells Control Adult Neural Stem Cell Quiescence and 
Maintenance through a Dynamic Balance between Direct and Indirect Pathways. 
Neuron 99, 493-510.e4 (2018). 
36. Deng, P. Y. et al. Cholecystokinin facilitates glutamate release by increasing the number 
of readily releasable vesicles and releasing probability. J. Neurosci. 30, 5136–5148 
(2010). 
37. Deng, P. Y. & Lei, S. Bidirectional modulation of GABAergic transmission by 
cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats. J. Physiol. 
572, 425–442 (2006). 
38. Müller, W., Heinemann, U. & Berlin, K. Cholecystokinin activates CCKB-receptor-
mediated Ca-signaling in hippocampal astrocytes. J. Neurophysiol. 78, 1997–2001 
(1997). 
39. Somogyi, J. et al. GABAergic basket cells expressing cholecystokinin contain vesicular 
glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and 
isocortex of the rat. Eur. J. Neurosci. 19, 552–569 (2004). 
40. Moran, T. H., Robinson, P. H., Goldrich, M. S. & McHugh, P. R. Two brain 
cholecystokinin receptors: implications for behavioral actions. Brain Res. 362, 175–179 
(1986). 
41. Hill, D. R., Campbell, N. J., Shaw, T. M. & Woodruff, G. N. Autoradiographic 
localization and biochemical characterization of peripheral type CCK receptors in rat 
CNS using highly selective nonpeptide CCK antagonists. J. Neurosci. 7, 2967–2976 
(1987). 
42. Rashidi, B. et al. Effect of cholecystokinin on learning and memory, neuronal 
proliferation and apoptosis in the rat hippocampus. Adv. Biomed. Res. 4, 227 (2015). 
43. Oldendorf, W. H. Blood-brain barrier permeability to peptides: Pitfalls in measurement. 
Peptides 2, 109–111 (1981). 
44. Taniguchi, H. et al. A Resource of Cre Driver Lines for Genetic Targeting of 
GABAergic Neurons in Cerebral Cortex. Neuron 71, 995–1013 (2011). 
45. Whissell, P. D. et al. Selective activation of cholecystokinin-expressing GABA (CCK-




46. Ludwig, M. et al. Intracellular calcium stores regulate activity-dependent neuropeptide 
release from dendrites. Nature 418, 85–89 (2002). 
47. Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. & Roth, B. L. Evolving the lock 
to fit the key to create a family of G protein-coupled receptors potently activated by an 
inert ligand. Proc. Natl. Acad. Sci. U. S. A. 104, 5163–5168 (2007). 
48. Huang, S. C. et al. Importance of sulfation of gastrin or cholecystokinin (CCK) on 
affinity for gastrin and CCK receptors. Peptides 10, 785–789 (1989). 
49. Acsády, L., Katona, I., Martínez-Guijarro, F. J., Buzsáki, G. & Freund, T. F. Unusual 
target selectivity of perisomatic inhibitory cells in the hilar region of the rat 
hippocampus. J. Neurosci. 20, 6907–6919 (2000). 
50. Espinoza, C., Guzman, S. J., Zhang, X. & Jonas, P. Parvalbumin + interneurons obey 
unique connectivity rules and establish a powerful lateral-inhibition microcircuit in 
dentate gyrus. Nat. Commun. 9, (2018). 
51. Fiacco, T. A. & McCarthy, K. D. Multiple lines of evidence indicate that 
gliotransmission does not occur under physiological conditions. J. Neurosci. 38, 3–13 
(2018). 
52. Hamilton, N. B. & Attwell, D. Do astrocytes really exocytose neurotransmitters? Nature 
Reviews Neuroscience vol. 11 227–238 (2010). 
53. Savtchouk, I. & Volterra, A. Gliotransmission: Beyond black-and-white. J. Neurosci. 
38, 14–25 (2018). 
54. Pabst, M. et al. Astrocyte Intermediaries of Septal Cholinergic Modulation in the 
Hippocampus. Neuron 90, 853–865 (2016). 
55. Swanson, R. A. & Graham, S. H. Fluorocitrate and fluoroacetate effects on astrocyte 
metabolism in vitro. Brain Res. 664, 94–100 (1994). 
56. Mederos, S. & Perea, G. GABAergic-astrocyte signaling: A refinement of inhibitory 
brain networks. GLIA (2019) doi:10.1002/glia.23644. 
57. Levin, M. Molecular bioelectricity: How endogenous voltage potentials control cell 
behavior and instruct pattern regulation in vivo. Mol. Biol. Cell 25, 3835–3850 (2014). 
58. Aprea, J. & Calegari, F. Bioelectric state and cell cycle control of mammalian neural 
stem cells. Stem Cells International (2012) doi:10.1155/2012/816049. 
59. Wang, J. Q., Fibuch, E. E. & Mao, L. Regulation of mitogen-activated protein kinases 
by glutamate receptors. Journal of Neurochemistry vol. 100 1–11 (2007). 
60. Chambard, J. C., Lefloch, R., Pouysségur, J. & Lenormand, P. ERK implication in cell 
cycle regulation. Biochimica et Biophysica Acta - Molecular Cell Research vol. 1773 
1299–1310 (2007). 
61. Wei, Z. & Liu, H. T. MAPK signal pathways in the regulation of cell proliferation in 




62. Duronio, R. J. & Xiong, Y. Signaling pathways that control cell proliferation. Cold 
Spring Harb. Perspect. Biol. 5, (2013). 
63. Arey, R. N. et al. An important role for Cholecystokinin, a CLOCK target gene, in the 
development and treatment of manic-like behaviors. Mol. Psychiatry 19, 342–350 
(2014). 
64. Liddelow, S. A. & Barres, B. A. Reactive Astrocytes: Production, Function, and 
Therapeutic Potential. Immunity vol. 46 957–967 (2017). 
65. Clarke, L. E. et al. Normal aging induces A1-like astrocyte reactivity. Proc. Natl. Acad. 
Sci. U. S. A. 115, E1896–E1905 (2018). 
66. Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391–
6410 (2012). 
67. Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, 
D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M.,  et al. 
Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 14, 388–405 (2015). 
68. Oakley, H. et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron 
loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential 
factors in amyloid plaque formation. J. Neurosci. 26, 10129–10140 (2006). 
69. Brunet, A. Nuclear translocation of p42/p44 mitogen-activated protein kinase is 
required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 
664–674 (1999). 
70. Nagao, M. et al. Coordinated control of self-renewal and differentiation of neural stem 
cells by Myc and the p19 ARF - p53 pathway. J. Cell Biol. 183, 1243–1257 (2008). 
71. Kerosuo, L. et al. Myc increases self-renewal in neural progenitor cells through Miz-1. 
J. Cell Sci. 121, 3941–3950 (2008). 
72. Lutterbach, B. & Hann, S. R. Hierarchical Phosphorylation at N-Terminal 
Transformation-Sensitive Sites in c-Myc Protein Is Regulated by Mitogens and in 
Mitosis. MOLECULAR AND CELLULAR BIOLOGY vol. 14 (1994). 
73. Henriksson, M., Bakardjiev, A., Klein, G. & Lüscher, B. Phosphorylation sites mapping 
in the N-terminal domain of c-myc modulate its transforming potential. undefined 
(1993). 
74. Babu, H., Cheung, G., Kettenmann, H., Palmer, T. D. & Kempermann, G. Enriched 
Monolayer Precursor Cell Cultures from Micro-Dissected Adult Mouse Dentate Gyrus 
Yield Functional Granule Cell-Like Neurons. PLoS One 2, e388 (2007). 
75. Berg, D. A. et al. A Common Embryonic Origin of Stem Cells Drives Developmental 
and Adult Neurogenesis. Cell 177, 654-668.e15 (2019). 
76. Sun, M. Y., Yetman, M. J., Lee, T. C., Chen, Y. & Jankowsky, J. L. Specificity and 
efficiency of reporter expression in adult neural progenitors vary substantially among 




77. Crowther, A. J. et al. An Adeno-Associated Virus-Based Toolkit for Preferential 
Targeting and Manipulating Quiescent Neural Stem Cells in the Adult Hippocampus. 
Stem Cell Reports 10, 1146–1159 (2018). 
78. Bao, H. et al. Long-Range GABAergic Inputs Regulate Neural Stem Cell Quiescence 
and Control Adult Hippocampal Neurogenesis. Cell Stem Cell 21, 604-617.e5 (2017). 
79. Sierra, A. et al. Neuronal hyperactivity accelerates depletion of neural stem cells and 
impairs hippocampal neurogenesis. Cell Stem Cell 16, 488–503 (2015). 
80. Armstrong, C. & Soltesz, I. Basket cell dichotomy in microcircuit function. Journal of 
Physiology vol. 590 683–694 (2012). 
81. Bartos, M. & Elgueta, C. Functional characteristics of parvalbumin- and 
cholecystokinin-expressing basket cells. Journal of Physiology vol. 590 669–681 
(2012). 
82. Medrihan, L. et al. Initiation of Behavioral Response to Antidepressants by 
Cholecystokinin Neurons of the Dentate Gyrus. Neuron 95, 564-576.e4 (2017). 
83. Lee, M. G., Hassani, O. K., Alonso, A. & Jones, B. E. Cholinergic basal forebrain 
neurons burst with theta during waking and paradoxical sleep. J. Neurosci. 25, 4365–
4369 (2005). 
84. Nagode, D. A., Tang, A.-H., Karson, M. A., Klugmann, M. & Alger, B. E. Optogenetic 
Release of ACh Induces Rhythmic Bursts of Perisomatic IPSCs in Hippocampus. PLoS 
One 6, e27691 (2011). 
85. Berchtold, N. C. et al. Hippocampal gene expression patterns linked to late-life physical 
activity oppose age and AD-related transcriptional decline. Neurobiol. Aging 78, 142–
154 (2019). 
86. Hensley, K. Neuroinflammation in Alzheimer’s disease: Mechanisms, pathologic 
consequences, and potential for therapeutic manipulation. Journal of Alzheimer’s 
Disease vol. 21 1–14 (2010). 
87. Meng, A. H., Ling, Y. L., Zhang, X. P. & Zhang, J. L. Anti-inflammatory effect of 
cholecystokinin and its signal transduction mechanism in endotoxic shock rat. World J. 
Gastroenterol. 8, 712–717 (2002). 
88. Miyamoto, S. et al. Cholecystokinin plays a novel protective role in diabetic kidney 
through anti-inflammatory actions on macrophage: Anti-inflammatory effect of 
cholecystokinin. Diabetes 61, 897–907 (2012). 
89. Oehlers, S. H. et al. A whole animal chemical screen approach to identify modifiers of 
intestinal neutrophilic inflammation. FEBS Journal vol. 284 402–413 (2017). 
90. Palop, J. J. et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling 
of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer’s Disease. Neuron 
55, 697–711 (2007). 




learning and memory retrieval. PLoS One 7, (2012). 
92. Iaccarino, H. F. et al. Gamma frequency entrainment attenuates amyloid load and 
modifies microglia. Nature 540, 230–235 (2016). 
93. Schmid, L. C. et al. Dysfunction of Somatostatin-Positive Interneurons Associated with 
Memory Deficits in an Alzheimer’s Disease Model. Neuron 92, 114–125 (2016). 
94. Sun, B. et al. Imbalance between GABAergic and Glutamatergic Transmission Impairs 
Adult Neurogenesis in an Animal Model of Alzheimer’s Disease. Cell Stem Cell 5, 624–
633 (2009). 
95. Verret, L. et al. Inhibitory interneuron deficit links altered network activity and 
cognitive dysfunction in alzheimer model. Cell 149, 708–721 (2012). 
 
